|
OMIM |
Link |
Information gain |
01 |
|
IBD5
|
[NCBI]
|
0.00235989
|
|
|
PSORS2
|
[NCBI]
|
0.00164498
|
|
|
ETM2
|
[NCBI]
|
0.00163986
|
|
|
IS1
|
[NCBI]
|
0.00157279
|
|
|
MCKD1
|
[NCBI]
|
0.00153226
|
|
|
EKD2
|
[NCBI]
|
0.00140045
|
|
|
HPC10
|
[NCBI]
|
0.00140045
|
|
|
PARK3
|
[NCBI]
|
0.00137001
|
|
|
neuropathy, hereditary motor and sensory, russe type
|
[NCBI]
|
0.00122911
|
|
|
RA
|
[NCBI]
|
0.00116008
|
|
|
IDDM
|
[NCBI]
|
0.00109263
|
|
|
MAFD1
|
[NCBI]
|
0.00106807
|
|
|
friedreich ataxia 2
|
[NCBI]
|
0.00105224
|
|
|
GLC3B
|
[NCBI]
|
0.00105224
|
|
|
ichthyosis prematurity syndrome
|
[NCBI]
|
0.00105224
|
|
|
MNG2
|
[NCBI]
|
0.00105224
|
|
|
SPG12
|
[NCBI]
|
0.000960311
|
|
|
hereditary motor and sensory neuropathy, type iic
|
[NCBI]
|
0.000960311
|
|
|
IGAD1
|
[NCBI]
|
0.000870241
|
|
|
HMN7A
|
[NCBI]
|
0.000821034
|
|
|
NIDDM2
|
[NCBI]
|
0.000821034
|
|
|
phenylketonuria
|
[NCBI]
|
0.000816899
|
|
|
OTSC1
|
[NCBI]
|
0.000814513
|
|
|
hypotrichosis, marie unna type
|
[NCBI]
|
0.000714731
|
|
|
duane retraction syndrome 2
|
[NCBI]
|
0.000714731
|
|
|
MSSE
|
[NCBI]
|
0.000714731
|
|
|
HSCR9
|
[NCBI]
|
0.00069953
|
|
|
diaphyseal medullary stenosis with malignant fibrous histiocytoma
|
[NCBI]
|
0.00069953
|
|
|
MCOPS4
|
[NCBI]
|
0.00069953
|
|
|
ALSFTD2
|
[NCBI]
|
0.00069953
|
|
|
myasthenia gravis with thymus hyperplasia
|
[NCBI]
|
0.00069953
|
|
|
ALS3
|
[NCBI]
|
0.00069953
|
|
|
amyotrophic lateral sclerosis 6
|
[NCBI]
|
0.00069953
|
|
|
CHDS8
|
[NCBI]
|
0.00069953
|
|
|
SPG19
|
[NCBI]
|
0.00069953
|
|
|
GLC1M
|
[NCBI]
|
0.00069953
|
|
|
MAFD6
|
[NCBI]
|
0.000639461
|
|
|
MCOPS1
|
[NCBI]
|
0.000629345
|
|
|
EGF
|
[NCBI]
|
0.000623881
|
|
|
SCZD6
|
[NCBI]
|
0.000558506
|
|
|
HMPS1
|
[NCBI]
|
0.000547033
|
|
|
CNA1
|
[NCBI]
|
0.000547033
|
|
|
MPD2
|
[NCBI]
|
0.000547033
|
|
|
CMT2B2
|
[NCBI]
|
0.000547033
|
|
|
ALSFTD1
|
[NCBI]
|
0.000547033
|
|
|
hypobetalipoproteinemia, familial, 2
|
[NCBI]
|
0.000547033
|
|
|
SCA19
|
[NCBI]
|
0.000547033
|
|
|
dyschromatosis universalis hereditaria
|
[NCBI]
|
0.000547033
|
|
|
AXPC1
|
[NCBI]
|
0.000547033
|
|
|
SCZD5
|
[NCBI]
|
0.000547033
|
|
|
KTCN3
|
[NCBI]
|
0.000525933
|
|
|
periodontitis, aggressive, 2
|
[NCBI]
|
0.000525933
|
|
|
AD15
|
[NCBI]
|
0.000525933
|
|
|
acropectorovertebral dysplasia, f-form of
|
[NCBI]
|
0.000525933
|
|
|
GLC1N
|
[NCBI]
|
0.000525933
|
|
|
knobloch syndrome, type ii
|
[NCBI]
|
0.000525933
|
|
|
myoclonic epilepsy, infantile
|
[NCBI]
|
0.000525933
|
|
|
HSCR5
|
[NCBI]
|
0.000525933
|
|
|
foveal hypoplasia and anterior segment dysgenesis
|
[NCBI]
|
0.000525933
|
|
|
IBD8
|
[NCBI]
|
0.000525933
|
|
|
MRXS11
|
[NCBI]
|
0.000525933
|
|
|
DFNA25
|
[NCBI]
|
0.000525933
|
|
|
GINGF2
|
[NCBI]
|
0.000525933
|
|
|
alzheimer disease 12
|
[NCBI]
|
0.000525933
|
|
|
spinal muscular atrophy, distal, x-linked recessive
|
[NCBI]
|
0.000525933
|
|
|
DFN6
|
[NCBI]
|
0.000525933
|
|
|
diamond-blackfan anemia 2
|
[NCBI]
|
0.000525933
|
|
|
LGMD1G
|
[NCBI]
|
0.000525933
|
|
|
acropectoral syndrome
|
[NCBI]
|
0.000525933
|
|
|
pseudohyperkalemia, familial, 2, due to red cell leak
|
[NCBI]
|
0.000525933
|
|
|
RP23
|
[NCBI]
|
0.000525933
|
|
|
EIG4
|
[NCBI]
|
0.000525933
|
|
|
STHAG5
|
[NCBI]
|
0.000525933
|
|
|
STGD4
|
[NCBI]
|
0.000525933
|
|
|
myopia 13
|
[NCBI]
|
0.000525933
|
|
|
FEB5
|
[NCBI]
|
0.000525933
|
|
|
DFNB26
|
[NCBI]
|
0.000525933
|
|
|
DFNA49
|
[NCBI]
|
0.000525933
|
|
|
SCKL3
|
[NCBI]
|
0.000525933
|
|
|
BMND7
|
[NCBI]
|
0.000525933
|
|
|
MRX78
|
[NCBI]
|
0.000525933
|
|
|
DFNB39
|
[NCBI]
|
0.000525933
|
|
|
DFNB62
|
[NCBI]
|
0.000525933
|
|
|
spondyloarthropathy, susceptibility to, 2
|
[NCBI]
|
0.000525933
|
|
|
SCA23
|
[NCBI]
|
0.000525933
|
|
|
orofacial cleft 9
|
[NCBI]
|
0.000525933
|
|
|
RP22
|
[NCBI]
|
0.000525933
|
|
|
hypotrichosis simplex
|
[NCBI]
|
0.000525933
|
|
|
amyotrophic lateral sclerosis 7
|
[NCBI]
|
0.000525933
|
|
|
STHAG2
|
[NCBI]
|
0.000525933
|
|
|
cataract, ataxia, short stature, and mental retardation
|
[NCBI]
|
0.000525933
|
|
|
aneurysm, intracranial berry, 4
|
[NCBI]
|
0.000525933
|
|
|
mycobacterium tuberculosis, susceptibility to, 1
|
[NCBI]
|
0.000525933
|
|
|
DFNB63
|
[NCBI]
|
0.000525933
|
|
|
noncompaction of left ventricular myocardium, familial isolated, autosomal dominant 2
|
[NCBI]
|
0.000525933
|
|
|
RP28
|
[NCBI]
|
0.000525933
|
|
|
RP33
|
[NCBI]
|
0.000525933
|
|
|
SLSN3
|
[NCBI]
|
0.000525933
|
|
|
GLC1B
|
[NCBI]
|
0.000525933
|
|
|
DFNA52
|
[NCBI]
|
0.000525933
|
|
|
GLC1D
|
[NCBI]
|
0.000525933
|
|
|
martin-probst deafness-mental retardation syndrome
|
[NCBI]
|
0.000525933
|
|
|
MMVP2
|
[NCBI]
|
0.000525933
|
|
|
glioma, familial, 1
|
[NCBI]
|
0.000525933
|
|
|
SPAX2
|
[NCBI]
|
0.000525933
|
|
|
PFM3
|
[NCBI]
|
0.000525933
|
|
|
myopathy, limb-girdle, with bone fragility
|
[NCBI]
|
0.000525933
|
|
|
SCA28
|
[NCBI]
|
0.000525933
|
|
|
DFNA43
|
[NCBI]
|
0.000525933
|
|
|
DFNM1
|
[NCBI]
|
0.000525933
|
|
|
OTSC2
|
[NCBI]
|
0.000525933
|
|
|
bleeding disorder, east texas type
|
[NCBI]
|
0.000525933
|
|
|
ATFB5
|
[NCBI]
|
0.000525933
|
|
|
polydactyly, postaxial, type a4
|
[NCBI]
|
0.000525933
|
|
|
ATFB2
|
[NCBI]
|
0.000525933
|
|
|
ETM3
|
[NCBI]
|
0.000525933
|
|
|
PNKD2
|
[NCBI]
|
0.000525933
|
|
|
FEB6
|
[NCBI]
|
0.000525933
|
|
|
generalized epilepsy with febrile seizures plus, type 4
|
[NCBI]
|
0.000525933
|
|
|
MCPH4
|
[NCBI]
|
0.000525933
|
|
|
FEB9
|
[NCBI]
|
0.000525933
|
|
|
immunoneurologic disorder, x-linked
|
[NCBI]
|
0.000525933
|
|
|
DFNA53
|
[NCBI]
|
0.000525933
|
|
|
PSORS1
|
[NCBI]
|
0.000514583
|
|
|
MDD
|
[NCBI]
|
0.000504985
|
|
|
SLE
|
[NCBI]
|
0.000496825
|
|
|
alzheimer disease 6
|
[NCBI]
|
0.000446562
|
|
|
syndactyly, type i
|
[NCBI]
|
0.000446303
|
|
|
AUTS5
|
[NCBI]
|
0.000446303
|
|
|
AD14
|
[NCBI]
|
0.000446303
|
|
|
CORD7
|
[NCBI]
|
0.000446303
|
|
|
x inactivation, familial skewed, 2
|
[NCBI]
|
0.000446303
|
|
|
glomerulopathy with fibronectin deposits
|
[NCBI]
|
0.000446303
|
|
|
AD13
|
[NCBI]
|
0.000446303
|
|
|
CRC
|
[NCBI]
|
0.000439931
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.000423778
|
|
|
trichoepithelioma, multiple familial
|
[NCBI]
|
0.00037206
|
|
|
IOSCA
|
[NCBI]
|
0.00037206
|
|
|
panbronchiolitis, diffuse
|
[NCBI]
|
0.00037206
|
|
|
CHED1
|
[NCBI]
|
0.00037206
|
|
|
UFS
|
[NCBI]
|
0.00037206
|
|
|
SRS
|
[NCBI]
|
0.000371763
|
|
|
SCZD
|
[NCBI]
|
0.000367798
|
|
|
CD
|
[NCBI]
|
0.000351709
|
|
|
MYP2
|
[NCBI]
|
0.000325844
|
|
|
EKD1
|
[NCBI]
|
0.000317358
|
|
|
spiegler-brooke syndrome
|
[NCBI]
|
0.000314124
|
|
|
NYS2
|
[NCBI]
|
0.000314124
|
|
|
MEAX
|
[NCBI]
|
0.000314124
|
|
|
PSORS4
|
[NCBI]
|
0.000314124
|
|
|
MYMY1
|
[NCBI]
|
0.000314124
|
|
|
thyroid carcinoma, nonmedullary, with or without cell oxyphilia
|
[NCBI]
|
0.000314124
|
|
|
MNG1
|
[NCBI]
|
0.000314124
|
|
|
ARMD4
|
[NCBI]
|
0.000301786
|
|
|
PRL
|
[NCBI]
|
0.000296177
|
|
|
lactase persistence
|
[NCBI]
|
0.000286763
|
|
|
acute myelogenous leukemia
|
[NCBI]
|
0.000273355
|
|
|
neuropathy, hereditary sensory and autonomic, type i, with cough and gastroesophageal reflux
|
[NCBI]
|
0.000273355
|
|
|
EA3
|
[NCBI]
|
0.000273355
|
|
|
DFNB13
|
[NCBI]
|
0.000273355
|
|
|
convulsions, benign familial infantile, 2
|
[NCBI]
|
0.000273355
|
|
|
HCFP2
|
[NCBI]
|
0.000273355
|
|
|
CMD1K
|
[NCBI]
|
0.000273355
|
|
|
SCAR5
|
[NCBI]
|
0.000273355
|
|
|
myasthenia, familial infantile, 1
|
[NCBI]
|
0.000273355
|
|
|
SCA25
|
[NCBI]
|
0.000273355
|
|
|
CMT2G
|
[NCBI]
|
0.000273355
|
|
|
DYT13
|
[NCBI]
|
0.000273355
|
|
|
thyroid carcinoma, nonmedullary 1
|
[NCBI]
|
0.000273355
|
|
|
SPAX1
|
[NCBI]
|
0.000273355
|
|
|
LGMD1F
|
[NCBI]
|
0.000273355
|
|
|
SPG14
|
[NCBI]
|
0.000273355
|
|
|
microcoria, congenital
|
[NCBI]
|
0.000273355
|
|
|
terminal osseous dysplasia and pigmentary defects
|
[NCBI]
|
0.000273355
|
|
|
LGMD2L
|
[NCBI]
|
0.000273355
|
|
|
hyperaldosteronism, familial, type ii
|
[NCBI]
|
0.000273355
|
|
|
myopathy, hyaline body, autosomal recessive
|
[NCBI]
|
0.000273355
|
|
|
NYS3
|
[NCBI]
|
0.000273355
|
|
|
MCOPCB2
|
[NCBI]
|
0.000273355
|
|
|
EC1
|
[NCBI]
|
0.000273355
|
|
|
spondyloepiphyseal dysplasia tarda, autosomal recessive
|
[NCBI]
|
0.000273355
|
|
|
brachydactyly, type a1, b
|
[NCBI]
|
0.000273355
|
|
|
NEM6
|
[NCBI]
|
0.000273355
|
|
|
cataract, autosomal recessive congenital 2
|
[NCBI]
|
0.000273355
|
|
|
HDL3
|
[NCBI]
|
0.000273355
|
|
|
ptosis, hereditary congenital 2
|
[NCBI]
|
0.000273355
|
|
|
PDB4
|
[NCBI]
|
0.000273355
|
|
|
PEE2
|
[NCBI]
|
0.000273355
|
|
|
NNCI
|
[NCBI]
|
0.000273355
|
|
|
CRCS1
|
[NCBI]
|
0.000273355
|
|
|
kala-azar, susceptibility to, 3
|
[NCBI]
|
0.000273355
|
|
|
ataxia, sensory, autosomal dominant
|
[NCBI]
|
0.000273355
|
|
|
systemic lupus erythematosus, susceptibility to, 8
|
[NCBI]
|
0.000273355
|
|
|
aortic aneurysm, familial thoracic 2
|
[NCBI]
|
0.000273355
|
|
|
IDDM6
|
[NCBI]
|
0.000273355
|
|
|
NYS4
|
[NCBI]
|
0.000273355
|
|
|
thyroid carcinoma, papillary, with papillary renal neoplasia
|
[NCBI]
|
0.000273355
|
|
|
epilepsy, partial, with variable foci
|
[NCBI]
|
0.000273355
|
|
|
MACOM
|
[NCBI]
|
0.000273355
|
|
|
kala-azar, susceptibility to, 2
|
[NCBI]
|
0.000273355
|
|
|
IBD7
|
[NCBI]
|
0.000273355
|
|
|
FCMD
|
[NCBI]
|
0.000269126
|
|
|
pulmonary disease, chronic obstructive
|
[NCBI]
|
0.000267287
|
|
|
gastroesophageal reflux
|
[NCBI]
|
0.000267287
|
|
|
AD
|
[NCBI]
|
0.00026312
|
|
|
CMT4A
|
[NCBI]
|
0.000258648
|
|
|
HNFJ
|
[NCBI]
|
0.000251685
|
|
|
NPY
|
[NCBI]
|
0.000251582
|
|
|
HBFQTL2
|
[NCBI]
|
0.000247231
|
|
|
ED2
|
[NCBI]
|
0.000246141
|
|
|
VEGF
|
[NCBI]
|
0.000236802
|
|
|
IBD1
|
[NCBI]
|
0.000236316
|
|
|
DTNBP1
|
[NCBI]
|
0.000232277
|
|
|
PXE
|
[NCBI]
|
0.000230951
|
|
|
SCZD7
|
[NCBI]
|
0.00022851
|
|
|
IBD2
|
[NCBI]
|
0.00022851
|
|
|
CMM
|
[NCBI]
|
0.00022736
|
|
|
PCNA
|
[NCBI]
|
0.000225876
|
|
|
LGMD2B
|
[NCBI]
|
0.000224865
|
|
|
HSCR1
|
[NCBI]
|
0.000224757
|
|
|
NRG1
|
[NCBI]
|
0.000223124
|
|
|
SCA7
|
[NCBI]
|
0.000222143
|
|
|
ACHE
|
[NCBI]
|
0.000222119
|
|
|
PWS
|
[NCBI]
|
0.000220124
|
|
|
AVP
|
[NCBI]
|
0.000215168
|
|
|
KLK3
|
[NCBI]
|
0.000213577
|
|
|
diabetes mellitus, insulin-dependent, 2
|
[NCBI]
|
0.00021105
|
|
|
DYT1
|
[NCBI]
|
0.000203329
|
|
|
osteoarthritis
|
[NCBI]
|
0.000200086
|
|
|
PTH
|
[NCBI]
|
0.000198925
|
|
|
corneal dystrophy, crystalline, of schnyder
|
[NCBI]
|
0.000195858
|
|
|
SHFLD1
|
[NCBI]
|
0.000195858
|
|
|
TOC
|
[NCBI]
|
0.000195858
|
|
|
SCZD3
|
[NCBI]
|
0.000195104
|
|
|
CAPN10
|
[NCBI]
|
0.000193483
|
|
|
CYLD
|
[NCBI]
|
0.000192318
|
|
|
EPO
|
[NCBI]
|
0.000190142
|
|
|
CDSN
|
[NCBI]
|
0.000190006
|
|
|
KNO
|
[NCBI]
|
0.000187112
|
|
|
pemphigus vulgaris, familial
|
[NCBI]
|
0.000187112
|
|
|
SPG16
|
[NCBI]
|
0.000185892
|
|
|
IDDM17
|
[NCBI]
|
0.000185892
|
|
|
wieacker syndrome
|
[NCBI]
|
0.000185892
|
|
|
MHAC
|
[NCBI]
|
0.000185892
|
|
|
neuropathy, hereditary motor and sensory, okinawa type
|
[NCBI]
|
0.000185892
|
|
|
SHFLD2
|
[NCBI]
|
0.000185892
|
|
|
migraine with or without aura, susceptibility to, 3
|
[NCBI]
|
0.000185892
|
|
|
OPA2
|
[NCBI]
|
0.000185892
|
|
|
laterality defects, autosomal dominant
|
[NCBI]
|
0.000185892
|
|
|
PSORS3
|
[NCBI]
|
0.000185892
|
|
|
CMTX3
|
[NCBI]
|
0.000185892
|
|
|
macular dystrophy, butterfly-shaped pigmentary, 2
|
[NCBI]
|
0.000185892
|
|
|
PARK10
|
[NCBI]
|
0.000185892
|
|
|
CND
|
[NCBI]
|
0.000185892
|
|
|
mesomelic dysplasia, kantaputra type
|
[NCBI]
|
0.000185892
|
|
|
cataract, central saccular, with sutural opacities
|
[NCBI]
|
0.000185892
|
|
|
systemic lupus erythematosus, susceptibility to, 7
|
[NCBI]
|
0.000185892
|
|
|
CFM1
|
[NCBI]
|
0.000185892
|
|
|
PSORS5
|
[NCBI]
|
0.000185892
|
|
|
van der woude syndrome modifier
|
[NCBI]
|
0.000185892
|
|
|
LI5
|
[NCBI]
|
0.000185892
|
|
|
SPG9
|
[NCBI]
|
0.000185892
|
|
|
CSE
|
[NCBI]
|
0.000185892
|
|
|
IBD6
|
[NCBI]
|
0.000185892
|
|
|
IDDM11
|
[NCBI]
|
0.000185892
|
|
|
AUTS10
|
[NCBI]
|
0.000185892
|
|
|
vacuolar neuromyopathy
|
[NCBI]
|
0.000185892
|
|
|
ORW3
|
[NCBI]
|
0.000185892
|
|
|
preauricular fistulae, congenital
|
[NCBI]
|
0.000185892
|
|
|
IBD9
|
[NCBI]
|
0.000185892
|
|
|
RET
|
[NCBI]
|
0.000184638
|
|
|
FRDA
|
[NCBI]
|
0.000182124
|
|
|
IL10
|
[NCBI]
|
0.000180411
|
|
|
CFH
|
[NCBI]
|
0.000179073
|
|
|
JBTS1
|
[NCBI]
|
0.000175752
|
|
|
BRCA1
|
[NCBI]
|
0.000174603
|
|
|
SCZD9
|
[NCBI]
|
0.000174017
|
|
|
erythrocytosis, familial, 2
|
[NCBI]
|
0.000174017
|
|
|
BHD
|
[NCBI]
|
0.000174017
|
|
|
KCS
|
[NCBI]
|
0.000172398
|
|
|
wilson disease
|
[NCBI]
|
0.000171098
|
|
|
human immunodeficiency virus type 1, susceptibility to
|
[NCBI]
|
0.000170371
|
|
|
MS
|
[NCBI]
|
0.000170348
|
|
|
leber optic atrophy
|
[NCBI]
|
0.000168042
|
|
|
WDM
|
[NCBI]
|
0.000168022
|
|
|
AUTS6
|
[NCBI]
|
0.000168022
|
|
|
PSNP1
|
[NCBI]
|
0.000167508
|
|
|
MG
|
[NCBI]
|
0.000166274
|
|
|
LDLR
|
[NCBI]
|
0.000163914
|
|
|
HBB
|
[NCBI]
|
0.000161182
|
|
|
SPG10
|
[NCBI]
|
0.000160236
|
|
|
CMT2D
|
[NCBI]
|
0.000160236
|
|
|
MAPT
|
[NCBI]
|
0.000160151
|
|
|
PARK6
|
[NCBI]
|
0.000158951
|
|
|
scleroderma, familial progressive
|
[NCBI]
|
0.000158093
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
0.000156231
|
|
|
LTA
|
[NCBI]
|
0.000154979
|
|
|
DYT3
|
[NCBI]
|
0.000152325
|
|
|
DYX2
|
[NCBI]
|
0.000152325
|
|
|
CLN8
|
[NCBI]
|
0.000149877
|
|
|
spinocerebellar ataxia, 16q22-linked
|
[NCBI]
|
0.000149877
|
|
|
CMT4C
|
[NCBI]
|
0.000149877
|
|
|
FHM1
|
[NCBI]
|
0.000147888
|
|
|
GLC1A
|
[NCBI]
|
0.000147116
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
0.000145797
|
|
|
respiratory distress syndrome in premature infants
|
[NCBI]
|
0.00014458
|
|
|
TS
|
[NCBI]
|
0.00014145
|
|
|
MPO
|
[NCBI]
|
0.000141094
|
|
|
SLSN4
|
[NCBI]
|
0.00014051
|
|
|
NPHP1
|
[NCBI]
|
0.000140484
|
|
|
HGF
|
[NCBI]
|
0.000137336
|
|
|
MCM6
|
[NCBI]
|
0.000137044
|
|
|
asthma, susceptibility to
|
[NCBI]
|
0.000136007
|
|
|
CCK
|
[NCBI]
|
0.000135736
|
|
|
graves disease
|
[NCBI]
|
0.00013549
|
|
|
APC
|
[NCBI]
|
0.000134614
|
|
|
HD
|
[NCBI]
|
0.000134015
|
|
|
SLS
|
[NCBI]
|
0.000133846
|
|
|
keratolytic winter erythema
|
[NCBI]
|
0.000133526
|
|
|
cholesterol level quantitative trait locus 1
|
[NCBI]
|
0.000133526
|
|
|
restless legs syndrome, susceptibility to, 6
|
[NCBI]
|
0.000133526
|
|
|
spinal muscular atrophy, distal, congenital nonprogressive
|
[NCBI]
|
0.000133526
|
|
|
DYT6
|
[NCBI]
|
0.000133526
|
|
|
HBFQTL3
|
[NCBI]
|
0.000133526
|
|
|
ICCA
|
[NCBI]
|
0.000133526
|
|
|
stature quantitative trait locus 3
|
[NCBI]
|
0.000133526
|
|
|
cholestasis-lymphedema syndrome
|
[NCBI]
|
0.000133526
|
|
|
MYP3
|
[NCBI]
|
0.000133526
|
|
|
asperger syndrome, susceptibility to, 1
|
[NCBI]
|
0.000133526
|
|
|
opioid dependence, susceptibility to, 1
|
[NCBI]
|
0.000133526
|
|
|
SCAR2
|
[NCBI]
|
0.000133526
|
|
|
nonpapillary renal carcinoma 1
|
[NCBI]
|
0.000133526
|
|
|
sclerotylosis
|
[NCBI]
|
0.000133526
|
|
|
CORD8
|
[NCBI]
|
0.000133526
|
|
|
LGMD1D
|
[NCBI]
|
0.000133526
|
|
|
charcot-marie-tooth disease, dominant intermediate a
|
[NCBI]
|
0.000133526
|
|
|
MRX23
|
[NCBI]
|
0.000133526
|
|
|
EA4
|
[NCBI]
|
0.000133526
|
|
|
DYX5
|
[NCBI]
|
0.000133526
|
|
|
ALS5
|
[NCBI]
|
0.000133526
|
|
|
MEHMO
|
[NCBI]
|
0.000133526
|
|
|
SLEB3
|
[NCBI]
|
0.000133526
|
|
|
peeling skin syndrome
|
[NCBI]
|
0.000133526
|
|
|
EVR3
|
[NCBI]
|
0.000133526
|
|
|
kala-azar, susceptibility to, 1
|
[NCBI]
|
0.000133526
|
|
|
speech-sound disorder
|
[NCBI]
|
0.000133526
|
|
|
CORD5
|
[NCBI]
|
0.000133526
|
|
|
cenani syndactylism
|
[NCBI]
|
0.000133526
|
|
|
amyotrophy, neurogenic scapuloperoneal, new england type
|
[NCBI]
|
0.000133526
|
|
|
BRCA3
|
[NCBI]
|
0.000133526
|
|
|
nasopharyngeal carcinoma 1
|
[NCBI]
|
0.000133526
|
|
|
CHDM
|
[NCBI]
|
0.000133526
|
|
|
klippel-trenaunay-weber syndrome
|
[NCBI]
|
0.000133437
|
|
|
DFNA6
|
[NCBI]
|
0.000132903
|
|
|
LGMD2H
|
[NCBI]
|
0.000132903
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
0.000131122
|
|
|
LI1
|
[NCBI]
|
0.000131122
|
|
|
GLC3A
|
[NCBI]
|
0.000130163
|
|
|
ATP7B
|
[NCBI]
|
0.000129668
|
|
|
bartter syndrome, infantile, with sensorineural deafness
|
[NCBI]
|
0.000129286
|
|
|
DFNB10
|
[NCBI]
|
0.000129286
|
|
|
SPG13
|
[NCBI]
|
0.000129286
|
|
|
nasopharyngeal carcinoma
|
[NCBI]
|
0.000129286
|
|
|
RP17
|
[NCBI]
|
0.000129286
|
|
|
MYOC
|
[NCBI]
|
0.000127727
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
0.000127564
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
0.000126657
|
|
|
SHEP1
|
[NCBI]
|
0.00012578
|
|
|
parkinson disease, mitochondrial
|
[NCBI]
|
0.00012578
|
|
|
PGL1
|
[NCBI]
|
0.000124605
|
|
|
PARK2
|
[NCBI]
|
0.000124605
|
|
|
CRH
|
[NCBI]
|
0.000124124
|
|
|
MRD
|
[NCBI]
|
0.000123325
|
|
|
FEB1
|
[NCBI]
|
0.000123325
|
|
|
IDDM4
|
[NCBI]
|
0.000123325
|
|
|
MBL2
|
[NCBI]
|
0.000121261
|
|
|
myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency
|
[NCBI]
|
0.000121041
|
|
|
APOA5
|
[NCBI]
|
0.000118963
|
|
|
TH
|
[NCBI]
|
0.000118667
|
|
|
MM
|
[NCBI]
|
0.00011804
|
|
|
AFP
|
[NCBI]
|
0.000116533
|
|
|
COMT
|
[NCBI]
|
0.000115885
|
|
|
BHC
|
[NCBI]
|
0.000113484
|
|
|
CJD
|
[NCBI]
|
0.00011265
|
|
|
CAT
|
[NCBI]
|
0.000110617
|
|
|
HFE
|
[NCBI]
|
0.000108519
|
|
|
pseudoxanthoma elasticum, forme fruste
|
[NCBI]
|
0.00010811
|
|
|
NPHP2
|
[NCBI]
|
0.000107794
|
|
|
MCKD2
|
[NCBI]
|
0.000107794
|
|
|
OPLL
|
[NCBI]
|
0.000107794
|
|
|
PARK4
|
[NCBI]
|
0.000107794
|
|
|
HHF1
|
[NCBI]
|
0.000106281
|
|
|
acromegaly
|
[NCBI]
|
0.000103155
|
|
|
IAHSP
|
[NCBI]
|
0.000102863
|
|
|
PPROM
|
[NCBI]
|
0.000102863
|
|
|
PEE4
|
[NCBI]
|
0.000102863
|
|
|
CFTR
|
[NCBI]
|
0.000102517
|
|
|
HLA-DQB1
|
[NCBI]
|
0.000102218
|
|
|
HMN2A
|
[NCBI]
|
9.96657e-05
|
|
|
NPHP3
|
[NCBI]
|
9.96657e-05
|
|
|
NPPA
|
[NCBI]
|
9.94828e-05
|
|
|
MTCO2
|
[NCBI]
|
9.87536e-05
|
|
|
camurati-engelmann disease
|
[NCBI]
|
9.85635e-05
|
|
|
SHFM5
|
[NCBI]
|
9.78311e-05
|
|
|
CELIAC2
|
[NCBI]
|
9.78311e-05
|
|
|
GLC1C
|
[NCBI]
|
9.78311e-05
|
|
|
migraine, familial typical, susceptibility to, 2
|
[NCBI]
|
9.78311e-05
|
|
|
OPA4
|
[NCBI]
|
9.78311e-05
|
|
|
lethal congenital contracture syndrome 1
|
[NCBI]
|
9.78311e-05
|
|
|
spondyloepiphyseal dysplasia tarda, autosomal dominant
|
[NCBI]
|
9.78311e-05
|
|
|
convulsions, benign familial infantile, 1
|
[NCBI]
|
9.78311e-05
|
|
|
malignant hyperthermia, susceptibility to, 2
|
[NCBI]
|
9.78311e-05
|
|
|
SCA4
|
[NCBI]
|
9.78311e-05
|
|
|
CTPP1
|
[NCBI]
|
9.78311e-05
|
|
|
electroencephalogram, low-voltage
|
[NCBI]
|
9.78311e-05
|
|
|
WT3
|
[NCBI]
|
9.78311e-05
|
|
|
pelizaeus-merzbacher-like disease, autosomal recessive, 2
|
[NCBI]
|
9.78311e-05
|
|
|
cerebellar ataxia and hypogonadotropic hypogonadism
|
[NCBI]
|
9.78311e-05
|
|
|
DYT7
|
[NCBI]
|
9.78311e-05
|
|
|
USH2B
|
[NCBI]
|
9.78311e-05
|
|
|
anosmia, congenital
|
[NCBI]
|
9.78311e-05
|
|
|
HTC2
|
[NCBI]
|
9.78311e-05
|
|
|
CF
|
[NCBI]
|
9.74485e-05
|
|
|
ABCC6
|
[NCBI]
|
9.73959e-05
|
|
|
BRCA2
|
[NCBI]
|
9.6968e-05
|
|
|
PPR
|
[NCBI]
|
9.51296e-05
|
|
|
PCLD
|
[NCBI]
|
9.42905e-05
|
|
|
spermatogenic failure, nonobstructive, y-linked
|
[NCBI]
|
9.3661e-05
|
|
|
autism
|
[NCBI]
|
9.33398e-05
|
|
|
PKD3
|
[NCBI]
|
9.26619e-05
|
|
|
SPG17
|
[NCBI]
|
9.26619e-05
|
|
|
hepatitis b virus, susceptibility to
|
[NCBI]
|
9.26619e-05
|
|
|
RYR1
|
[NCBI]
|
9.08827e-05
|
|
|
PARK8
|
[NCBI]
|
9.02992e-05
|
|
|
HEPOD
|
[NCBI]
|
9.02992e-05
|
|
|
DURS1
|
[NCBI]
|
8.94922e-05
|
|
|
SCA6
|
[NCBI]
|
8.91442e-05
|
|
|
SLC11A1
|
[NCBI]
|
8.90302e-05
|
|
|
amyloidosis vi
|
[NCBI]
|
8.81175e-05
|
|
|
IDE
|
[NCBI]
|
8.80906e-05
|
|
|
F3
|
[NCBI]
|
8.76066e-05
|
|
|
SLSN1
|
[NCBI]
|
8.65232e-05
|
|
|
DFNA12
|
[NCBI]
|
8.65232e-05
|
|
|
SCA14
|
[NCBI]
|
8.65232e-05
|
|
|
PRTS
|
[NCBI]
|
8.61823e-05
|
|
|
bietti crystalline corneoretinal dystrophy
|
[NCBI]
|
8.61823e-05
|
|
|
orofacial cleft 5
|
[NCBI]
|
8.61823e-05
|
|
|
CCL
|
[NCBI]
|
8.61823e-05
|
|
|
FSGS2
|
[NCBI]
|
8.61823e-05
|
|
|
lactase deficiency, congenital
|
[NCBI]
|
8.61823e-05
|
|
|
USH1F
|
[NCBI]
|
8.61823e-05
|
|
|
LI3
|
[NCBI]
|
8.61823e-05
|
|
|
ALDH3A2
|
[NCBI]
|
8.55504e-05
|
|
|
BBS
|
[NCBI]
|
8.36808e-05
|
|
|
mucolipidosis iv
|
[NCBI]
|
8.30432e-05
|
|
|
sialuria, finnish type
|
[NCBI]
|
8.30432e-05
|
|
|
OCA2
|
[NCBI]
|
8.20399e-05
|
|
|
CLN5
|
[NCBI]
|
8.10715e-05
|
|
|
amyloidosis, primary cutaneous
|
[NCBI]
|
8.10715e-05
|
|
|
SACS
|
[NCBI]
|
8.10715e-05
|
|
|
sarcoidosis
|
[NCBI]
|
8.10715e-05
|
|
|
PPD2
|
[NCBI]
|
8.10715e-05
|
|
|
CMT2B
|
[NCBI]
|
8.10715e-05
|
|
|
SMN1
|
[NCBI]
|
8.09376e-05
|
|
|
CSNB1A
|
[NCBI]
|
7.97302e-05
|
|
|
DRD4
|
[NCBI]
|
7.97041e-05
|
|
|
TPH2
|
[NCBI]
|
7.86086e-05
|
|
|
MCOLN1
|
[NCBI]
|
7.86086e-05
|
|
|
MICA
|
[NCBI]
|
7.71393e-05
|
|
|
HLA-DRB1
|
[NCBI]
|
7.65628e-05
|
|
|
ARH
|
[NCBI]
|
7.61791e-05
|
|
|
THC2
|
[NCBI]
|
7.61791e-05
|
|
|
CMT2A1
|
[NCBI]
|
7.61791e-05
|
|
|
FTNS
|
[NCBI]
|
7.61791e-05
|
|
|
NCIE1
|
[NCBI]
|
7.61791e-05
|
|
|
CRYGD
|
[NCBI]
|
7.61614e-05
|
|
|
NOD2
|
[NCBI]
|
7.60803e-05
|
|
|
CTNS
|
[NCBI]
|
7.50072e-05
|
|
|
NPHP4
|
[NCBI]
|
7.49222e-05
|
|
|
cystinosis, late-onset juvenile or adolescent nephropathic type
|
[NCBI]
|
7.49222e-05
|
|
|
NAIC
|
[NCBI]
|
7.49222e-05
|
|
|
EDM3
|
[NCBI]
|
7.49222e-05
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
7.39327e-05
|
|
|
ALOX5AP
|
[NCBI]
|
7.39132e-05
|
|
|
MHA
|
[NCBI]
|
7.36386e-05
|
|
|
CCHCR1
|
[NCBI]
|
7.30968e-05
|
|
|
DYT1
|
[NCBI]
|
7.23743e-05
|
|
|
MJD
|
[NCBI]
|
7.21224e-05
|
|
|
HCFP1
|
[NCBI]
|
7.19552e-05
|
|
|
MKS2
|
[NCBI]
|
7.19552e-05
|
|
|
RNANC
|
[NCBI]
|
7.19552e-05
|
|
|
fanconi renotubular syndrome
|
[NCBI]
|
7.19552e-05
|
|
|
hemangioma, capillary infantile
|
[NCBI]
|
7.19552e-05
|
|
|
PGL2
|
[NCBI]
|
7.19552e-05
|
|
|
SCAX1
|
[NCBI]
|
7.19552e-05
|
|
|
vestibulopathy, familial
|
[NCBI]
|
7.19552e-05
|
|
|
SCZD10
|
[NCBI]
|
7.19552e-05
|
|
|
CCA1
|
[NCBI]
|
7.19552e-05
|
|
|
systemic lupus erythematosus, susceptibility to, 6
|
[NCBI]
|
7.19552e-05
|
|
|
macular edema, cystoid
|
[NCBI]
|
7.19552e-05
|
|
|
complement component 7 deficiency
|
[NCBI]
|
7.17508e-05
|
|
|
LGMD2I
|
[NCBI]
|
7.17508e-05
|
|
|
sitosterolemia
|
[NCBI]
|
7.17508e-05
|
|
|
STGD3
|
[NCBI]
|
7.17508e-05
|
|
|
HMN5
|
[NCBI]
|
7.17508e-05
|
|
|
dyschromatosis symmetrica hereditaria 1
|
[NCBI]
|
7.08292e-05
|
|
|
SMA2
|
[NCBI]
|
7.08292e-05
|
|
|
C4A
|
[NCBI]
|
7.0304e-05
|
|
|
LCT
|
[NCBI]
|
7.02782e-05
|
|
|
DFNB37
|
[NCBI]
|
7.02507e-05
|
|
|
NNO2
|
[NCBI]
|
7.02507e-05
|
|
|
CATCN3
|
[NCBI]
|
7.02507e-05
|
|
|
pancreatitis, sclerosing cholangitis, and sicca complex
|
[NCBI]
|
7.02507e-05
|
|
|
leukocyte nuclear appendages, hereditary prevalence of
|
[NCBI]
|
7.02507e-05
|
|
|
HHF5
|
[NCBI]
|
7.02507e-05
|
|
|
skin fragility-woolly hair syndrome
|
[NCBI]
|
7.02507e-05
|
|
|
NEM5
|
[NCBI]
|
7.02507e-05
|
|
|
epilepsy, x-linked, with variable learning disabilities and behavior disorders
|
[NCBI]
|
7.02507e-05
|
|
|
PCH6
|
[NCBI]
|
7.02507e-05
|
|
|
osteoarthritis of distal interphalangeal joints
|
[NCBI]
|
7.02507e-05
|
|
|
ATFB3
|
[NCBI]
|
7.02507e-05
|
|
|
immotile cilia syndrome due to excessively long cilia
|
[NCBI]
|
7.02507e-05
|
|
|
hypodontia, x-linked
|
[NCBI]
|
7.02507e-05
|
|
|
cataract-ataxia-deafness-retardation syndrome
|
[NCBI]
|
7.02507e-05
|
|
|
coronary heart disease, susceptibility to, 7
|
[NCBI]
|
7.02507e-05
|
|
|
erythema nodosum, familial
|
[NCBI]
|
7.02507e-05
|
|
|
cataract, cortical, juvenile-onset
|
[NCBI]
|
7.02507e-05
|
|
|
cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome
|
[NCBI]
|
7.02507e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2h
|
[NCBI]
|
7.02507e-05
|
|
|
streptococcus, group a, severity of infection by
|
[NCBI]
|
7.02507e-05
|
|
|
systemic lupus erythematosus, susceptibility to, 9
|
[NCBI]
|
7.02507e-05
|
|
|
craniosynostosis syndrome, autosomal recessive
|
[NCBI]
|
7.02507e-05
|
|
|
NEM4
|
[NCBI]
|
7.02507e-05
|
|
|
hyperimmunoglobulin g1(a1) syndrome
|
[NCBI]
|
7.02507e-05
|
|
|
DISC1
|
[NCBI]
|
6.98581e-05
|
|
|
EVC
|
[NCBI]
|
6.816e-05
|
|
|
tibial muscular dystrophy, tardive
|
[NCBI]
|
6.77141e-05
|
|
|
JH
|
[NCBI]
|
6.77141e-05
|
|
|
PPCD1
|
[NCBI]
|
6.77141e-05
|
|
|
CAPN3
|
[NCBI]
|
6.75266e-05
|
|
|
WAS
|
[NCBI]
|
6.73344e-05
|
|
|
neural tube defects, x-linked
|
[NCBI]
|
6.64359e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2b1
|
[NCBI]
|
6.64359e-05
|
|
|
DFNB8
|
[NCBI]
|
6.64359e-05
|
|
|
CNA2
|
[NCBI]
|
6.64359e-05
|
|
|
EVR4
|
[NCBI]
|
6.64359e-05
|
|
|
minicore myopathy with external ophthalmoplegia
|
[NCBI]
|
6.64359e-05
|
|
|
HLA-B
|
[NCBI]
|
6.64224e-05
|
|
|
MTND6
|
[NCBI]
|
6.64224e-05
|
|
|
oca2 gene
|
[NCBI]
|
6.64224e-05
|
|
|
VDR
|
[NCBI]
|
6.6335e-05
|
|
|
LMBR1
|
[NCBI]
|
6.61873e-05
|
|
|
PLEKHG4
|
[NCBI]
|
6.60399e-05
|
|
|
myoclonic epilepsy of lafora
|
[NCBI]
|
6.562e-05
|
|
|
NCSTN
|
[NCBI]
|
6.48102e-05
|
|
|
FMO3
|
[NCBI]
|
6.43242e-05
|
|
|
PARK2
|
[NCBI]
|
6.30951e-05
|
|
|
NIDDM
|
[NCBI]
|
6.22665e-05
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
6.12002e-05
|
|
|
ASPM
|
[NCBI]
|
6.09252e-05
|
|
|
NRCLP1
|
[NCBI]
|
6.08892e-05
|
|
|
ICP
|
[NCBI]
|
6.06001e-05
|
|
|
DHRD
|
[NCBI]
|
6.06001e-05
|
|
|
NPHS1
|
[NCBI]
|
6.06001e-05
|
|
|
CYP1B1
|
[NCBI]
|
6.05263e-05
|
|
|
OPTN
|
[NCBI]
|
6.05103e-05
|
|
|
FA
|
[NCBI]
|
6.02181e-05
|
|
|
CLN6
|
[NCBI]
|
5.9657e-05
|
|
|
charcot-marie-tooth disease, dominant intermediate b
|
[NCBI]
|
5.9657e-05
|
|
|
EJM1
|
[NCBI]
|
5.9657e-05
|
|
|
SCA5
|
[NCBI]
|
5.9657e-05
|
|
|
MPD1
|
[NCBI]
|
5.9657e-05
|
|
|
ALS4
|
[NCBI]
|
5.9657e-05
|
|
|
pierson syndrome
|
[NCBI]
|
5.9657e-05
|
|
|
FSGS1
|
[NCBI]
|
5.9657e-05
|
|
|
LGMD2J
|
[NCBI]
|
5.9657e-05
|
|
|
SHEP3
|
[NCBI]
|
5.9657e-05
|
|
|
PRKCSH
|
[NCBI]
|
5.94722e-05
|
|
|
ADAM33
|
[NCBI]
|
5.94722e-05
|
|
|
PMM2
|
[NCBI]
|
5.92381e-05
|
|
|
CRYGC
|
[NCBI]
|
5.8699e-05
|
|
|
CVID
|
[NCBI]
|
5.81272e-05
|
|
|
FKRP
|
[NCBI]
|
5.80095e-05
|
|
|
EA2
|
[NCBI]
|
5.7441e-05
|
|
|
ADH2
|
[NCBI]
|
5.57115e-05
|
|
|
OPA1
|
[NCBI]
|
5.57115e-05
|
|
|
PCSK9
|
[NCBI]
|
5.48258e-05
|
|
|
HSPA1L
|
[NCBI]
|
5.48195e-05
|
|
|
g72 gene
|
[NCBI]
|
5.48195e-05
|
|
|
ABCB1
|
[NCBI]
|
5.47904e-05
|
|
|
LGMD2A
|
[NCBI]
|
5.45486e-05
|
|
|
HIDS
|
[NCBI]
|
5.4505e-05
|
|
|
TRMA
|
[NCBI]
|
5.40403e-05
|
|
|
GS1
|
[NCBI]
|
5.40403e-05
|
|
|
CMT4B1
|
[NCBI]
|
5.40403e-05
|
|
|
HRD
|
[NCBI]
|
5.40403e-05
|
|
|
IBM3
|
[NCBI]
|
5.40403e-05
|
|
|
VMCM
|
[NCBI]
|
5.40403e-05
|
|
|
DMD
|
[NCBI]
|
5.35945e-05
|
|
|
MHS1
|
[NCBI]
|
5.31131e-05
|
|
|
CCM
|
[NCBI]
|
5.31131e-05
|
|
|
ATD1
|
[NCBI]
|
5.30119e-05
|
|
|
SHFM3
|
[NCBI]
|
5.30119e-05
|
|
|
MASTL
|
[NCBI]
|
5.28993e-05
|
|
|
cytochrome p450, family 4, subfamily v, polypeptide 2
|
[NCBI]
|
5.28993e-05
|
|
|
ECA1
|
[NCBI]
|
5.25681e-05
|
|
|
SHFM2
|
[NCBI]
|
5.25681e-05
|
|
|
BMND3
|
[NCBI]
|
5.25681e-05
|
|
|
acetabular dysplasia
|
[NCBI]
|
5.25681e-05
|
|
|
schistosoma mansoni infection, susceptibility/resistance to
|
[NCBI]
|
5.25681e-05
|
|
|
DBQD
|
[NCBI]
|
5.25681e-05
|
|
|
PHP
|
[NCBI]
|
5.25681e-05
|
|
|
pseudohyperkalemia, familial, 1, due to red cell leak
|
[NCBI]
|
5.25681e-05
|
|
|
mental health wellness 1
|
[NCBI]
|
5.25681e-05
|
|
|
HMN1
|
[NCBI]
|
5.25681e-05
|
|
|
ORW2
|
[NCBI]
|
5.1767e-05
|
|
|
PLOSL
|
[NCBI]
|
5.1767e-05
|
|
|
CRYBB2
|
[NCBI]
|
5.1537e-05
|
|
|
COL18A1
|
[NCBI]
|
5.1537e-05
|
|
|
IRF6
|
[NCBI]
|
5.1537e-05
|
|
|
AIRE
|
[NCBI]
|
5.13964e-05
|
|
|
SORL1
|
[NCBI]
|
5.11923e-05
|
|
|
chromosome 17q21.31 microdeletion syndrome
|
[NCBI]
|
5.11923e-05
|
|
|
IL23R
|
[NCBI]
|
5.11923e-05
|
|
|
LRRK2
|
[NCBI]
|
5.1033e-05
|
|
|
walker-warburg syndrome
|
[NCBI]
|
5.07509e-05
|
|
|
FCAS
|
[NCBI]
|
5.07509e-05
|
|
|
APS1
|
[NCBI]
|
5.06938e-05
|
|
|
ARPKD
|
[NCBI]
|
5.01969e-05
|
|
|
SLC45A2
|
[NCBI]
|
5.00626e-05
|
|
|
C7
|
[NCBI]
|
5.00626e-05
|
|
|
CYP2D6
|
[NCBI]
|
5.00176e-05
|
|
|
AGT
|
[NCBI]
|
4.93937e-05
|
|
|
HFE3
|
[NCBI]
|
4.92674e-05
|
|
|
CMH4
|
[NCBI]
|
4.92674e-05
|
|
|
SBS
|
[NCBI]
|
4.92674e-05
|
|
|
DMC
|
[NCBI]
|
4.92674e-05
|
|
|
NIDDM1
|
[NCBI]
|
4.92674e-05
|
|
|
SPG11
|
[NCBI]
|
4.92674e-05
|
|
|
CMT4B2
|
[NCBI]
|
4.92674e-05
|
|
|
currarino syndrome
|
[NCBI]
|
4.92674e-05
|
|
|
OPTA2
|
[NCBI]
|
4.92674e-05
|
|
|
tobacco addiction, susceptibility to
|
[NCBI]
|
4.92674e-05
|
|
|
INAD1
|
[NCBI]
|
4.92674e-05
|
|
|
dyskeratosis congenita, autosomal dominant
|
[NCBI]
|
4.92674e-05
|
|
|
ETM1
|
[NCBI]
|
4.9206e-05
|
|
|
OPA1
|
[NCBI]
|
4.89653e-05
|
|
|
MEB
|
[NCBI]
|
4.89653e-05
|
|
|
TRIM32
|
[NCBI]
|
4.82154e-05
|
|
|
VKORC1
|
[NCBI]
|
4.82154e-05
|
|
|
GPR154
|
[NCBI]
|
4.82154e-05
|
|
|
MYH7
|
[NCBI]
|
4.81852e-05
|
|
|
MSH2
|
[NCBI]
|
4.81852e-05
|
|
|
SNCA
|
[NCBI]
|
4.81397e-05
|
|
|
COH1
|
[NCBI]
|
4.72493e-05
|
|
|
ulcerative colitis, susceptibility to
|
[NCBI]
|
4.68043e-05
|
|
|
megaloblastic anemia 1
|
[NCBI]
|
4.68043e-05
|
|
|
PJS
|
[NCBI]
|
4.66975e-05
|
|
|
FANCA
|
[NCBI]
|
4.57898e-05
|
|
|
SACS
|
[NCBI]
|
4.56909e-05
|
|
|
MKKS
|
[NCBI]
|
4.56909e-05
|
|
|
BSCL2
|
[NCBI]
|
4.56909e-05
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
4.55989e-05
|
|
|
BWS
|
[NCBI]
|
4.51846e-05
|
|
|
NETH
|
[NCBI]
|
4.51358e-05
|
|
|
PARK1
|
[NCBI]
|
4.51358e-05
|
|
|
schwannomatosis
|
[NCBI]
|
4.51358e-05
|
|
|
ATLD
|
[NCBI]
|
4.51358e-05
|
|
|
afibrinogenemia, congenital
|
[NCBI]
|
4.51358e-05
|
|
|
JWS
|
[NCBI]
|
4.51358e-05
|
|
|
BRIC1
|
[NCBI]
|
4.51358e-05
|
|
|
CSNB2A
|
[NCBI]
|
4.51358e-05
|
|
|
severe cutaneous adverse reaction, susceptibility to
|
[NCBI]
|
4.51358e-05
|
|
|
hyperostosis corticalis generalisata
|
[NCBI]
|
4.51358e-05
|
|
|
erythermalgia, primary
|
[NCBI]
|
4.51358e-05
|
|
|
CMT4D
|
[NCBI]
|
4.51358e-05
|
|
|
USH1D
|
[NCBI]
|
4.51358e-05
|
|
|
NYS1
|
[NCBI]
|
4.51358e-05
|
|
|
DFNA2
|
[NCBI]
|
4.51358e-05
|
|
|
HEMB
|
[NCBI]
|
4.51219e-05
|
|
|
SCA1
|
[NCBI]
|
4.48325e-05
|
|
|
glycogen storage disease iii
|
[NCBI]
|
4.45465e-05
|
|
|
ESR1
|
[NCBI]
|
4.42892e-05
|
|
|
aneurysm, intracranial berry, 1
|
[NCBI]
|
4.37591e-05
|
|
|
TNFRSF1B
|
[NCBI]
|
4.36471e-05
|
|
|
CCL11
|
[NCBI]
|
4.35002e-05
|
|
|
SLC19A2
|
[NCBI]
|
4.35002e-05
|
|
|
LMAN1
|
[NCBI]
|
4.35002e-05
|
|
|
AR
|
[NCBI]
|
4.3467e-05
|
|
|
LOCS
|
[NCBI]
|
4.30869e-05
|
|
|
PPCD3
|
[NCBI]
|
4.30869e-05
|
|
|
NFTC
|
[NCBI]
|
4.30869e-05
|
|
|
chromosome 9q subtelomeric deletion syndrome
|
[NCBI]
|
4.30869e-05
|
|
|
tetra-amelia, autosomal recessive
|
[NCBI]
|
4.30869e-05
|
|
|
MKS4
|
[NCBI]
|
4.30869e-05
|
|
|
mast syndrome
|
[NCBI]
|
4.30869e-05
|
|
|
deafness, congenital, with total albinism
|
[NCBI]
|
4.30869e-05
|
|
|
aortic aneurysm, familial thoracic 3
|
[NCBI]
|
4.30869e-05
|
|
|
PTHS
|
[NCBI]
|
4.30869e-05
|
|
|
radial aplasia, x-linked
|
[NCBI]
|
4.30869e-05
|
|
|
epilepsy, myoclonic, x-linked, with mental retardation and spasticity
|
[NCBI]
|
4.30869e-05
|
|
|
diabetes mellitus, transient neonatal, 3
|
[NCBI]
|
4.30869e-05
|
|
|
obesity, susceptibility to, x-linked
|
[NCBI]
|
4.30869e-05
|
|
|
LCCS2
|
[NCBI]
|
4.30869e-05
|
|
|
SHEP4
|
[NCBI]
|
4.30869e-05
|
|
|
amelogenesis imperfecta, pigmented hypomaturation type
|
[NCBI]
|
4.30869e-05
|
|
|
blepharospasm, benign essential
|
[NCBI]
|
4.30869e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2l
|
[NCBI]
|
4.30869e-05
|
|
|
CMT2K
|
[NCBI]
|
4.30869e-05
|
|
|
peeling skin syndrome, acral type
|
[NCBI]
|
4.30869e-05
|
|
|
NFRCD
|
[NCBI]
|
4.30869e-05
|
|
|
IS3
|
[NCBI]
|
4.30869e-05
|
|
|
cataract, crystalline aculeiform
|
[NCBI]
|
4.30869e-05
|
|
|
electroencephalographic peculiarity: fronto-precentral beta wave groups
|
[NCBI]
|
4.30869e-05
|
|
|
CMH8
|
[NCBI]
|
4.30869e-05
|
|
|
CLSD
|
[NCBI]
|
4.30869e-05
|
|
|
PLGL
|
[NCBI]
|
4.30869e-05
|
|
|
SCA16
|
[NCBI]
|
4.30869e-05
|
|
|
uric acid nephrolithiasis, susceptibility to
|
[NCBI]
|
4.30869e-05
|
|
|
PPCD2
|
[NCBI]
|
4.30869e-05
|
|
|
orofacial cleft 6
|
[NCBI]
|
4.30869e-05
|
|
|
MCPHA
|
[NCBI]
|
4.30869e-05
|
|
|
muscular dystrophy, scapulohumeral
|
[NCBI]
|
4.30869e-05
|
|
|
DFNA44
|
[NCBI]
|
4.30869e-05
|
|
|
CCA3
|
[NCBI]
|
4.30869e-05
|
|
|
charcot-marie-tooth disease, dominant intermediate c
|
[NCBI]
|
4.30869e-05
|
|
|
alcohol dependence
|
[NCBI]
|
4.24196e-05
|
|
|
CRYAA
|
[NCBI]
|
4.18849e-05
|
|
|
MTND3
|
[NCBI]
|
4.18849e-05
|
|
|
STOX1
|
[NCBI]
|
4.16088e-05
|
|
|
CYLD1
|
[NCBI]
|
4.15664e-05
|
|
|
AMN
|
[NCBI]
|
4.15664e-05
|
|
|
HNPCC2
|
[NCBI]
|
4.15083e-05
|
|
|
LGMD1A
|
[NCBI]
|
4.15083e-05
|
|
|
BDA1
|
[NCBI]
|
4.15083e-05
|
|
|
BDB1
|
[NCBI]
|
4.15083e-05
|
|
|
CDKN2A
|
[NCBI]
|
4.13912e-05
|
|
|
IGER
|
[NCBI]
|
4.10072e-05
|
|
|
SRD5A2
|
[NCBI]
|
4.09398e-05
|
|
|
MYH9
|
[NCBI]
|
4.09398e-05
|
|
|
TGM1
|
[NCBI]
|
4.09398e-05
|
|
|
LRP5
|
[NCBI]
|
4.09398e-05
|
|
|
AIS
|
[NCBI]
|
4.09064e-05
|
|
|
CHS
|
[NCBI]
|
4.09064e-05
|
|
|
CCR5
|
[NCBI]
|
4.04793e-05
|
|
|
PDB
|
[NCBI]
|
4.04121e-05
|
|
|
thiourea tasting
|
[NCBI]
|
4.04121e-05
|
|
|
PNKD1
|
[NCBI]
|
4.04121e-05
|
|
|
MCPH1
|
[NCBI]
|
3.98366e-05
|
|
|
BFSP2
|
[NCBI]
|
3.98366e-05
|
|
|
ADH3
|
[NCBI]
|
3.98366e-05
|
|
|
FLCN
|
[NCBI]
|
3.98366e-05
|
|
|
IRF5
|
[NCBI]
|
3.98366e-05
|
|
|
GNRH1
|
[NCBI]
|
3.96236e-05
|
|
|
TNFSF6
|
[NCBI]
|
3.95755e-05
|
|
|
SLC22A5
|
[NCBI]
|
3.91711e-05
|
|
|
diabetes insipidus, nephrogenic, x-linked
|
[NCBI]
|
3.85139e-05
|
|
|
LCA1
|
[NCBI]
|
3.85139e-05
|
|
|
PRNP
|
[NCBI]
|
3.83091e-05
|
|
|
SFD
|
[NCBI]
|
3.82876e-05
|
|
|
congenital cataracts, facial dysmorphism, and neuropathy
|
[NCBI]
|
3.82876e-05
|
|
|
acheiropody
|
[NCBI]
|
3.82876e-05
|
|
|
KIR3DL1
|
[NCBI]
|
3.82728e-05
|
|
|
NDRG1
|
[NCBI]
|
3.82728e-05
|
|
|
JPS
|
[NCBI]
|
3.82154e-05
|
|
|
short rib-polydactyly syndrome, type iii
|
[NCBI]
|
3.77934e-05
|
|
|
myoclonic epilepsy, juvenile, 3
|
[NCBI]
|
3.77934e-05
|
|
|
alzheimer disease 8
|
[NCBI]
|
3.77934e-05
|
|
|
strabismus, susceptibility to
|
[NCBI]
|
3.77934e-05
|
|
|
MTACR1
|
[NCBI]
|
3.77934e-05
|
|
|
prostate cancer, hereditary, 8
|
[NCBI]
|
3.77934e-05
|
|
|
APOB
|
[NCBI]
|
3.77089e-05
|
|
|
CACNA1A
|
[NCBI]
|
3.76278e-05
|
|
|
ARX
|
[NCBI]
|
3.75445e-05
|
|
|
DM2
|
[NCBI]
|
3.68924e-05
|
|
|
TCIRG1
|
[NCBI]
|
3.68469e-05
|
|
|
CRYGA
|
[NCBI]
|
3.68469e-05
|
|
|
HLA-C
|
[NCBI]
|
3.68469e-05
|
|
|
SFTPA1
|
[NCBI]
|
3.68469e-05
|
|
|
OPTB1
|
[NCBI]
|
3.67163e-05
|
|
|
EFHC1
|
[NCBI]
|
3.65443e-05
|
|
|
PSMB8
|
[NCBI]
|
3.65443e-05
|
|
|
IDUA
|
[NCBI]
|
3.63463e-05
|
|
|
PRODH
|
[NCBI]
|
3.60403e-05
|
|
|
FBN1
|
[NCBI]
|
3.58303e-05
|
|
|
MAOA
|
[NCBI]
|
3.58303e-05
|
|
|
MCDR1
|
[NCBI]
|
3.56946e-05
|
|
|
PRX
|
[NCBI]
|
3.55372e-05
|
|
|
APOC3
|
[NCBI]
|
3.55372e-05
|
|
|
TECTA
|
[NCBI]
|
3.55372e-05
|
|
|
HSPD1
|
[NCBI]
|
3.55372e-05
|
|
|
ACCPN
|
[NCBI]
|
3.54022e-05
|
|
|
autoimmune disease
|
[NCBI]
|
3.54022e-05
|
|
|
ALS2
|
[NCBI]
|
3.54022e-05
|
|
|
NM
|
[NCBI]
|
3.54022e-05
|
|
|
KFSD
|
[NCBI]
|
3.54022e-05
|
|
|
USH3
|
[NCBI]
|
3.54022e-05
|
|
|
wolff-parkinson-white syndrome
|
[NCBI]
|
3.54022e-05
|
|
|
synovitis, granulomatous, with uveitis and cranial neuropathies
|
[NCBI]
|
3.54022e-05
|
|
|
SHH
|
[NCBI]
|
3.53674e-05
|
|
|
SPDA1
|
[NCBI]
|
3.50116e-05
|
|
|
BOR1
|
[NCBI]
|
3.50116e-05
|
|
|
PPARA
|
[NCBI]
|
3.47287e-05
|
|
|
AT
|
[NCBI]
|
3.46858e-05
|
|
|
ENPP1
|
[NCBI]
|
3.46425e-05
|
|
|
DYSF
|
[NCBI]
|
3.46425e-05
|
|
|
ABCC8
|
[NCBI]
|
3.46423e-05
|
|
|
GDAP1
|
[NCBI]
|
3.4327e-05
|
|
|
PDCD1
|
[NCBI]
|
3.4327e-05
|
|
|
BMPR2
|
[NCBI]
|
3.4327e-05
|
|
|
CTNS
|
[NCBI]
|
3.4327e-05
|
|
|
AGL
|
[NCBI]
|
3.4327e-05
|
|
|
PKHD1
|
[NCBI]
|
3.4327e-05
|
|
|
SGSH
|
[NCBI]
|
3.4327e-05
|
|
|
GNRHR
|
[NCBI]
|
3.4181e-05
|
|
|
VHL
|
[NCBI]
|
3.41526e-05
|
|
|
CNTF
|
[NCBI]
|
3.39578e-05
|
|
|
ATM
|
[NCBI]
|
3.35043e-05
|
|
|
complement component 2 deficiency
|
[NCBI]
|
3.33383e-05
|
|
|
DFNB67
|
[NCBI]
|
3.3214e-05
|
|
|
spastic ataxia
|
[NCBI]
|
3.3214e-05
|
|
|
steatocystoma multiplex
|
[NCBI]
|
3.3214e-05
|
|
|
crisponi syndrome
|
[NCBI]
|
3.3214e-05
|
|
|
MRT3
|
[NCBI]
|
3.3214e-05
|
|
|
SCA11
|
[NCBI]
|
3.3214e-05
|
|
|
EDM5
|
[NCBI]
|
3.3214e-05
|
|
|
fundus dystrophy, pseudoinflammatory, recessive form
|
[NCBI]
|
3.3214e-05
|
|
|
DFNB31
|
[NCBI]
|
3.3214e-05
|
|
|
CELIAC3
|
[NCBI]
|
3.3214e-05
|
|
|
ATOD4
|
[NCBI]
|
3.3214e-05
|
|
|
MRX63
|
[NCBI]
|
3.3214e-05
|
|
|
aortic aneurysm, familial thoracic 4
|
[NCBI]
|
3.3214e-05
|
|
|
LBSL
|
[NCBI]
|
3.3214e-05
|
|
|
epstein-barr virus, susceptibility to chronic infection by
|
[NCBI]
|
3.3214e-05
|
|
|
axenfeld-rieger anomaly with partially absent eye muscles, distinctive face, hydrocephaly, and skeletal abnormalities
|
[NCBI]
|
3.3214e-05
|
|
|
MADB
|
[NCBI]
|
3.3214e-05
|
|
|
cafe-au-lait spots, multiple
|
[NCBI]
|
3.3214e-05
|
|
|
dystonia, familial, with visual failure and striatal lucencies
|
[NCBI]
|
3.3214e-05
|
|
|
FECD1
|
[NCBI]
|
3.3214e-05
|
|
|
OPTB4
|
[NCBI]
|
3.3214e-05
|
|
|
FEB4
|
[NCBI]
|
3.3214e-05
|
|
|
stroke, susceptibility to, 1
|
[NCBI]
|
3.3214e-05
|
|
|
MCOPCB3
|
[NCBI]
|
3.3214e-05
|
|
|
S CHOICE OF
|
[NCBI]
|
3.3214e-05
|
|
|
LVNCX
|
[NCBI]
|
3.3214e-05
|
|
|
SPS
|
[NCBI]
|
3.3214e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2f
|
[NCBI]
|
3.3214e-05
|
|
|
DFNB16
|
[NCBI]
|
3.3214e-05
|
|
|
LORD
|
[NCBI]
|
3.3214e-05
|
|
|
dermatitis herpetiformis, familial
|
[NCBI]
|
3.3214e-05
|
|
|
HMERF
|
[NCBI]
|
3.3214e-05
|
|
|
HHS
|
[NCBI]
|
3.3214e-05
|
|
|
SHEP5
|
[NCBI]
|
3.3214e-05
|
|
|
hepatitis b vaccine, response to
|
[NCBI]
|
3.3214e-05
|
|
|
deafness, sensorineural, and male infertility
|
[NCBI]
|
3.3214e-05
|
|
|
leprosy, susceptibility to, 4
|
[NCBI]
|
3.3214e-05
|
|
|
neuropathy, hereditary sensory, with spastic paraplegia, autosomal recessive
|
[NCBI]
|
3.3214e-05
|
|
|
SLEB2
|
[NCBI]
|
3.3214e-05
|
|
|
BOS3
|
[NCBI]
|
3.3214e-05
|
|
|
PLIN
|
[NCBI]
|
3.32029e-05
|
|
|
NPHS1
|
[NCBI]
|
3.32029e-05
|
|
|
CYP2C9
|
[NCBI]
|
3.32029e-05
|
|
|
ATP1A2
|
[NCBI]
|
3.32029e-05
|
|
|
TCP10
|
[NCBI]
|
3.30897e-05
|
|
|
g30 gene
|
[NCBI]
|
3.30897e-05
|
|
|
NFKBIL1
|
[NCBI]
|
3.30897e-05
|
|
|
DCDC2
|
[NCBI]
|
3.30897e-05
|
|
|
TAAR5
|
[NCBI]
|
3.30897e-05
|
|
|
CCL24
|
[NCBI]
|
3.30897e-05
|
|
|
multiple coagulation factor deficiency protein 2
|
[NCBI]
|
3.30897e-05
|
|
|
NYX
|
[NCBI]
|
3.30897e-05
|
|
|
SH3TC2
|
[NCBI]
|
3.30897e-05
|
|
|
CHI3L1
|
[NCBI]
|
3.30897e-05
|
|
|
SLC25A12
|
[NCBI]
|
3.30897e-05
|
|
|
CLN6
|
[NCBI]
|
3.30897e-05
|
|
|
CORDX1
|
[NCBI]
|
3.2798e-05
|
|
|
protocadherin-alpha gene cluster
|
[NCBI]
|
3.2798e-05
|
|
|
SPD1
|
[NCBI]
|
3.2798e-05
|
|
|
CDS
|
[NCBI]
|
3.2798e-05
|
|
|
cri-du-chat syndrome
|
[NCBI]
|
3.2798e-05
|
|
|
USH1C
|
[NCBI]
|
3.2798e-05
|
|
|
WGN1
|
[NCBI]
|
3.2798e-05
|
|
|
trichodentoosseous syndrome
|
[NCBI]
|
3.2798e-05
|
|
|
CASR
|
[NCBI]
|
3.26283e-05
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
3.20358e-05
|
|
|
DHFR
|
[NCBI]
|
3.18833e-05
|
|
|
TSD
|
[NCBI]
|
3.17991e-05
|
|
|
SLC26A4
|
[NCBI]
|
3.15342e-05
|
|
|
GJA3
|
[NCBI]
|
3.1171e-05
|
|
|
ADRB2
|
[NCBI]
|
3.09691e-05
|
|
|
HHT
|
[NCBI]
|
3.0921e-05
|
|
|
BIRC1
|
[NCBI]
|
3.08003e-05
|
|
|
PTHLH
|
[NCBI]
|
3.07849e-05
|
|
|
GABRA4
|
[NCBI]
|
3.04586e-05
|
|
|
CHST6
|
[NCBI]
|
3.04586e-05
|
|
|
MFRP
|
[NCBI]
|
3.04586e-05
|
|
|
BTNL2
|
[NCBI]
|
3.04586e-05
|
|
|
HMCN1
|
[NCBI]
|
3.04586e-05
|
|
|
GAN1
|
[NCBI]
|
3.04331e-05
|
|
|
leprosy, susceptibility to
|
[NCBI]
|
3.04331e-05
|
|
|
muckle-wells syndrome
|
[NCBI]
|
3.04331e-05
|
|
|
SOST
|
[NCBI]
|
3.04331e-05
|
|
|
BCPM
|
[NCBI]
|
3.0389e-05
|
|
|
FPLD2
|
[NCBI]
|
3.0389e-05
|
|
|
PTPN22
|
[NCBI]
|
3.02471e-05
|
|
|
XRCC9
|
[NCBI]
|
3.02471e-05
|
|
|
GUCY2D
|
[NCBI]
|
3.02471e-05
|
|
|
SMN2
|
[NCBI]
|
2.98876e-05
|
|
|
DES
|
[NCBI]
|
2.98876e-05
|
|
|
OCP
|
[NCBI]
|
2.98425e-05
|
|
|
DDC
|
[NCBI]
|
2.93912e-05
|
|
|
C9
|
[NCBI]
|
2.93756e-05
|
|
|
protoporphyria, erythropoietic
|
[NCBI]
|
2.93697e-05
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
2.89935e-05
|
|
|
FCHL
|
[NCBI]
|
2.89935e-05
|
|
|
HLA-DRA
|
[NCBI]
|
2.88659e-05
|
|
|
CUBN
|
[NCBI]
|
2.85515e-05
|
|
|
TNXB
|
[NCBI]
|
2.85515e-05
|
|
|
GJB6
|
[NCBI]
|
2.85515e-05
|
|
|
DSP
|
[NCBI]
|
2.85515e-05
|
|
|
SCA2
|
[NCBI]
|
2.83724e-05
|
|
|
P2RY12
|
[NCBI]
|
2.83347e-05
|
|
|
ARIX
|
[NCBI]
|
2.83347e-05
|
|
|
VPS13A
|
[NCBI]
|
2.83347e-05
|
|
|
SLURP1
|
[NCBI]
|
2.83347e-05
|
|
|
ADH4
|
[NCBI]
|
2.83347e-05
|
|
|
myofibrillogenesis regulator 1
|
[NCBI]
|
2.83347e-05
|
|
|
CLN8
|
[NCBI]
|
2.83347e-05
|
|
|
ATP2C1
|
[NCBI]
|
2.83347e-05
|
|
|
locus control region, beta
|
[NCBI]
|
2.83347e-05
|
|
|
TAP2
|
[NCBI]
|
2.83347e-05
|
|
|
NPHP4
|
[NCBI]
|
2.83347e-05
|
|
|
PFM
|
[NCBI]
|
2.82742e-05
|
|
|
infantile sialic acid storage disorder
|
[NCBI]
|
2.82742e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
2.82203e-05
|
|
|
POLG
|
[NCBI]
|
2.78983e-05
|
|
|
TNF
|
[NCBI]
|
2.77906e-05
|
|
|
MC1R
|
[NCBI]
|
2.77405e-05
|
|
|
SPG3A
|
[NCBI]
|
2.76629e-05
|
|
|
PON1
|
[NCBI]
|
2.7126e-05
|
|
|
SDHD
|
[NCBI]
|
2.70276e-05
|
|
|
RHD
|
[NCBI]
|
2.70276e-05
|
|
|
WFS1
|
[NCBI]
|
2.70276e-05
|
|
|
HAE III
|
[NCBI]
|
2.70164e-05
|
|
|
homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cble complementation type
|
[NCBI]
|
2.70164e-05
|
|
|
leprosy, susceptibility to, 2
|
[NCBI]
|
2.70164e-05
|
|
|
CFEOM2
|
[NCBI]
|
2.70164e-05
|
|
|
retinitis pigmentosa-deafness syndrome
|
[NCBI]
|
2.70164e-05
|
|
|
charcot-marie-tooth disease, axonal, with vocal cord paresis, autosomal recessive
|
[NCBI]
|
2.70164e-05
|
|
|
CELIAC4
|
[NCBI]
|
2.70164e-05
|
|
|
RP18
|
[NCBI]
|
2.70164e-05
|
|
|
cryohydrocytosis, stomatin-deficient, with mental retardation, seizures, cataracts, and massive hepatosplenomegaly
|
[NCBI]
|
2.70164e-05
|
|
|
rett syndrome, atypical, cdkl5-related
|
[NCBI]
|
2.70164e-05
|
|
|
RCM1
|
[NCBI]
|
2.70164e-05
|
|
|
allergic rhinitis
|
[NCBI]
|
2.70164e-05
|
|
|
CORDX3
|
[NCBI]
|
2.70164e-05
|
|
|
cataract, autosomal dominant, multiple types 1
|
[NCBI]
|
2.70164e-05
|
|
|
corneal fleck dystrophy
|
[NCBI]
|
2.70164e-05
|
|
|
DPR
|
[NCBI]
|
2.70164e-05
|
|
|
asthma-related traits, susceptibility to, 2
|
[NCBI]
|
2.70164e-05
|
|
|
laurence-moon syndrome
|
[NCBI]
|
2.70164e-05
|
|
|
platelet disorder, familial, with associated myeloid malignancy
|
[NCBI]
|
2.70164e-05
|
|
|
pseudohyperkalemia cardiff
|
[NCBI]
|
2.70164e-05
|
|
|
OPTB2
|
[NCBI]
|
2.70164e-05
|
|
|
pelizaeus-merzbacher-like disease, autosomal recessive, 1
|
[NCBI]
|
2.70164e-05
|
|
|
vitamin k-dependent clotting factors, combined deficiency of, 2
|
[NCBI]
|
2.70164e-05
|
|
|
SCA13
|
[NCBI]
|
2.70164e-05
|
|
|
PRD
|
[NCBI]
|
2.70164e-05
|
|
|
familial mediterranean fever, autosomal dominant
|
[NCBI]
|
2.70164e-05
|
|
|
complement component 4, partial deficiency of
|
[NCBI]
|
2.70164e-05
|
|
|
dyserythropoietic anemia with thrombocytopenia
|
[NCBI]
|
2.70164e-05
|
|
|
simpson-golabi-behmel syndrome, type 2
|
[NCBI]
|
2.70164e-05
|
|
|
MCOP2
|
[NCBI]
|
2.70164e-05
|
|
|
DFNB59
|
[NCBI]
|
2.70164e-05
|
|
|
CLN7
|
[NCBI]
|
2.70164e-05
|
|
|
MLH1
|
[NCBI]
|
2.68853e-05
|
|
|
HLXB9
|
[NCBI]
|
2.65558e-05
|
|
|
LAMB2
|
[NCBI]
|
2.65558e-05
|
|
|
SRD5A1
|
[NCBI]
|
2.65558e-05
|
|
|
USH3A
|
[NCBI]
|
2.65558e-05
|
|
|
EVPL
|
[NCBI]
|
2.65558e-05
|
|
|
CRYBB1
|
[NCBI]
|
2.65558e-05
|
|
|
SLC22A4
|
[NCBI]
|
2.65558e-05
|
|
|
TCF7L2
|
[NCBI]
|
2.6538e-05
|
|
|
CTSC
|
[NCBI]
|
2.6538e-05
|
|
|
GCY
|
[NCBI]
|
2.64678e-05
|
|
|
IGES
|
[NCBI]
|
2.64678e-05
|
|
|
RNPEPL1
|
[NCBI]
|
2.64486e-05
|
|
|
KRT24
|
[NCBI]
|
2.64486e-05
|
|
|
CYP4F22
|
[NCBI]
|
2.64486e-05
|
|
|
otopetrin 3
|
[NCBI]
|
2.64486e-05
|
|
|
asthma-associated alternatively spliced gene 1
|
[NCBI]
|
2.64486e-05
|
|
|
SPG25
|
[NCBI]
|
2.64486e-05
|
|
|
otopetrin 1
|
[NCBI]
|
2.64486e-05
|
|
|
otopetrin 2
|
[NCBI]
|
2.64486e-05
|
|
|
mmachc gene
|
[NCBI]
|
2.64486e-05
|
|
|
KIR3DP1
|
[NCBI]
|
2.64486e-05
|
|
|
SPATA16
|
[NCBI]
|
2.64486e-05
|
|
|
radial ray deficiency, x-linked
|
[NCBI]
|
2.64486e-05
|
|
|
g8 protein
|
[NCBI]
|
2.64486e-05
|
|
|
AMY1B
|
[NCBI]
|
2.64486e-05
|
|
|
MIAT
|
[NCBI]
|
2.64486e-05
|
|
|
SPG4
|
[NCBI]
|
2.6393e-05
|
|
|
infantile spasm syndrome, x-linked
|
[NCBI]
|
2.62946e-05
|
|
|
hydatidiform mole
|
[NCBI]
|
2.62946e-05
|
|
|
hyperlipoproteinemia, type i
|
[NCBI]
|
2.62946e-05
|
|
|
CORD2
|
[NCBI]
|
2.62946e-05
|
|
|
diarrhea 1, secretory chloride, congenital
|
[NCBI]
|
2.62946e-05
|
|
|
EVR1
|
[NCBI]
|
2.62946e-05
|
|
|
neuropathy, congenital hypomyelinating
|
[NCBI]
|
2.62946e-05
|
|
|
VWS
|
[NCBI]
|
2.58635e-05
|
|
|
TNFRSF11B
|
[NCBI]
|
2.54747e-05
|
|
|
GTS
|
[NCBI]
|
2.52884e-05
|
|
|
RP2
|
[NCBI]
|
2.5275e-05
|
|
|
PCTT
|
[NCBI]
|
2.51801e-05
|
|
|
TBCE
|
[NCBI]
|
2.50275e-05
|
|
|
CLCNKB
|
[NCBI]
|
2.50275e-05
|
|
|
SDC3
|
[NCBI]
|
2.50275e-05
|
|
|
IRF2
|
[NCBI]
|
2.50275e-05
|
|
|
FGF20
|
[NCBI]
|
2.50275e-05
|
|
|
CYSLTR1
|
[NCBI]
|
2.50275e-05
|
|
|
SCN1A
|
[NCBI]
|
2.50012e-05
|
|
|
OPMD
|
[NCBI]
|
2.48165e-05
|
|
|
MTND1
|
[NCBI]
|
2.44815e-05
|
|
|
FHM2
|
[NCBI]
|
2.44725e-05
|
|
|
FTLDU
|
[NCBI]
|
2.44725e-05
|
|
|
IL4R
|
[NCBI]
|
2.4384e-05
|
|
|
SMA3
|
[NCBI]
|
2.4021e-05
|
|
|
CLN3
|
[NCBI]
|
2.4021e-05
|
|
|
malaria, susceptibility to
|
[NCBI]
|
2.4021e-05
|
|
|
CMTX1
|
[NCBI]
|
2.4021e-05
|
|
|
TIMP3
|
[NCBI]
|
2.37923e-05
|
|
|
ELOVL4
|
[NCBI]
|
2.36896e-05
|
|
|
CLDN16
|
[NCBI]
|
2.36896e-05
|
|
|
CDKL5
|
[NCBI]
|
2.36896e-05
|
|
|
CNGB3
|
[NCBI]
|
2.36896e-05
|
|
|
ATP8B1
|
[NCBI]
|
2.36896e-05
|
|
|
PSMB9
|
[NCBI]
|
2.36896e-05
|
|
|
LQT1
|
[NCBI]
|
2.31958e-05
|
|
|
ACH
|
[NCBI]
|
2.31227e-05
|
|
|
PGM1
|
[NCBI]
|
2.29976e-05
|
|
|
CDG1A
|
[NCBI]
|
2.29124e-05
|
|
|
GBA
|
[NCBI]
|
2.28052e-05
|
|
|
HRPT1
|
[NCBI]
|
2.27897e-05
|
|
|
IBM2
|
[NCBI]
|
2.27897e-05
|
|
|
GEFS+
|
[NCBI]
|
2.27897e-05
|
|
|
CBAVD
|
[NCBI]
|
2.27897e-05
|
|
|
pseudohypoparathyroidism, type ib
|
[NCBI]
|
2.27897e-05
|
|
|
von willebrand disease
|
[NCBI]
|
2.27591e-05
|
|
|
MUC1
|
[NCBI]
|
2.27359e-05
|
|
|
GSTP1
|
[NCBI]
|
2.26784e-05
|
|
|
PSEN2
|
[NCBI]
|
2.26463e-05
|
|
|
IDDM10
|
[NCBI]
|
2.25644e-05
|
|
|
PFM2
|
[NCBI]
|
2.25644e-05
|
|
|
DFNA10
|
[NCBI]
|
2.25644e-05
|
|
|
pyogenic sterile arthritis, pyoderma gangrenosum, and acne
|
[NCBI]
|
2.25644e-05
|
|
|
MKS3
|
[NCBI]
|
2.25644e-05
|
|
|
PGL3
|
[NCBI]
|
2.25644e-05
|
|
|
LVNC1
|
[NCBI]
|
2.25644e-05
|
|
|
STL3
|
[NCBI]
|
2.25644e-05
|
|
|
myopathy, centronuclear, autosomal recessive
|
[NCBI]
|
2.25644e-05
|
|
|
CTPP3
|
[NCBI]
|
2.25644e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive
|
[NCBI]
|
2.25644e-05
|
|
|
HCHOLA3
|
[NCBI]
|
2.25644e-05
|
|
|
LCA2
|
[NCBI]
|
2.25644e-05
|
|
|
seizures, benign familial neonatal-infantile
|
[NCBI]
|
2.25644e-05
|
|
|
vasculopathy, retinal, with cerebral leukodystrophy
|
[NCBI]
|
2.25644e-05
|
|
|
DFNB12
|
[NCBI]
|
2.25644e-05
|
|
|
asthma-related traits, susceptibility to, 1
|
[NCBI]
|
2.25644e-05
|
|
|
MRX54
|
[NCBI]
|
2.25644e-05
|
|
|
retinitis pigmentosa, x-linked, with recurrent respiratory infections
|
[NCBI]
|
2.25644e-05
|
|
|
KRS
|
[NCBI]
|
2.25644e-05
|
|
|
LI2
|
[NCBI]
|
2.25644e-05
|
|
|
RP15
|
[NCBI]
|
2.25644e-05
|
|
|
weyers acrofacial dysostosis
|
[NCBI]
|
2.25644e-05
|
|
|
ebstein anomaly
|
[NCBI]
|
2.25644e-05
|
|
|
DFNB6
|
[NCBI]
|
2.25644e-05
|
|
|
CMH3
|
[NCBI]
|
2.25644e-05
|
|
|
tropical calcific pancreatitis
|
[NCBI]
|
2.25644e-05
|
|
|
asthma-related traits, susceptibility to, 5
|
[NCBI]
|
2.25644e-05
|
|
|
melorheostosis
|
[NCBI]
|
2.25644e-05
|
|
|
osteogenesis imperfecta, type viii
|
[NCBI]
|
2.25644e-05
|
|
|
PDB1
|
[NCBI]
|
2.25644e-05
|
|
|
SLC17A5
|
[NCBI]
|
2.25014e-05
|
|
|
CTSS
|
[NCBI]
|
2.25014e-05
|
|
|
INPPL1
|
[NCBI]
|
2.25014e-05
|
|
|
PRKAA2
|
[NCBI]
|
2.25014e-05
|
|
|
PEX1
|
[NCBI]
|
2.25014e-05
|
|
|
RGS4
|
[NCBI]
|
2.25014e-05
|
|
|
LAMA3
|
[NCBI]
|
2.25014e-05
|
|
|
AAAS
|
[NCBI]
|
2.25014e-05
|
|
|
RPGR
|
[NCBI]
|
2.23024e-05
|
|
|
complement component 6 deficiency
|
[NCBI]
|
2.21531e-05
|
|
|
KCNJ11
|
[NCBI]
|
2.21531e-05
|
|
|
HBD
|
[NCBI]
|
2.19656e-05
|
|
|
MEN1
|
[NCBI]
|
2.17847e-05
|
|
|
ACE
|
[NCBI]
|
2.17353e-05
|
|
|
ALPL
|
[NCBI]
|
2.1647e-05
|
|
|
IL1A
|
[NCBI]
|
2.1647e-05
|
|
|
KCNQ1
|
[NCBI]
|
2.16356e-05
|
|
|
IL2
|
[NCBI]
|
2.15415e-05
|
|
|
SOST
|
[NCBI]
|
2.14341e-05
|
|
|
SCN8A
|
[NCBI]
|
2.14341e-05
|
|
|
CX3CR1
|
[NCBI]
|
2.14341e-05
|
|
|
PITX3
|
[NCBI]
|
2.14341e-05
|
|
|
NLRP3
|
[NCBI]
|
2.14341e-05
|
|
|
UBQLN1
|
[NCBI]
|
2.14341e-05
|
|
|
KCNQ4
|
[NCBI]
|
2.14341e-05
|
|
|
ZNF9
|
[NCBI]
|
2.14341e-05
|
|
|
MERTK
|
[NCBI]
|
2.14341e-05
|
|
|
PKD2
|
[NCBI]
|
2.13122e-05
|
|
|
SCA10
|
[NCBI]
|
2.12312e-05
|
|
|
AAA
|
[NCBI]
|
2.12312e-05
|
|
|
MSS
|
[NCBI]
|
2.12312e-05
|
|
|
KTCN1
|
[NCBI]
|
2.12312e-05
|
|
|
IL12B
|
[NCBI]
|
2.11589e-05
|
|
|
NF2
|
[NCBI]
|
2.09952e-05
|
|
|
prostate cancer
|
[NCBI]
|
2.07672e-05
|
|
|
MATN3
|
[NCBI]
|
2.04663e-05
|
|
|
RMRP
|
[NCBI]
|
2.04663e-05
|
|
|
CLCN7
|
[NCBI]
|
2.04663e-05
|
|
|
FKTN
|
[NCBI]
|
2.04663e-05
|
|
|
HHEX
|
[NCBI]
|
2.04663e-05
|
|
|
PPOX
|
[NCBI]
|
2.02326e-05
|
|
|
GSN
|
[NCBI]
|
2.02326e-05
|
|
|
CMH
|
[NCBI]
|
2.01563e-05
|
|
|
GH1
|
[NCBI]
|
2.01275e-05
|
|
|
CYP1A1
|
[NCBI]
|
1.9883e-05
|
|
|
POAG
|
[NCBI]
|
1.98635e-05
|
|
|
ICAM1
|
[NCBI]
|
1.97925e-05
|
|
|
UCMD
|
[NCBI]
|
1.97841e-05
|
|
|
NHS
|
[NCBI]
|
1.97841e-05
|
|
|
APL
|
[NCBI]
|
1.97841e-05
|
|
|
SCA17
|
[NCBI]
|
1.97841e-05
|
|
|
GARS
|
[NCBI]
|
1.9582e-05
|
|
|
ATXN2
|
[NCBI]
|
1.9582e-05
|
|
|
CA4
|
[NCBI]
|
1.9582e-05
|
|
|
LDLRAP1
|
[NCBI]
|
1.9582e-05
|
|
|
MSR1
|
[NCBI]
|
1.9582e-05
|
|
|
OLR1
|
[NCBI]
|
1.9582e-05
|
|
|
alsin
|
[NCBI]
|
1.9582e-05
|
|
|
CYP3A5
|
[NCBI]
|
1.9582e-05
|
|
|
MYO7A
|
[NCBI]
|
1.93665e-05
|
|
|
GJB2
|
[NCBI]
|
1.93552e-05
|
|
|
CHH
|
[NCBI]
|
1.9269e-05
|
|
|
protocadherin-beta gene cluster
|
[NCBI]
|
1.91406e-05
|
|
|
methylmalonic aciduria, cbla type
|
[NCBI]
|
1.91406e-05
|
|
|
buschke-ollendorff syndrome
|
[NCBI]
|
1.91406e-05
|
|
|
pyruvate dehydrogenase e3-binding protein deficiency
|
[NCBI]
|
1.91406e-05
|
|
|
OCA4
|
[NCBI]
|
1.91406e-05
|
|
|
OCA1B
|
[NCBI]
|
1.91406e-05
|
|
|
PRTH
|
[NCBI]
|
1.91406e-05
|
|
|
HOA
|
[NCBI]
|
1.91406e-05
|
|
|
scapuloperoneal syndrome, neurogenic, kaeser type
|
[NCBI]
|
1.91406e-05
|
|
|
noonan-like/multiple giant cell lesion syndrome
|
[NCBI]
|
1.91406e-05
|
|
|
UL
|
[NCBI]
|
1.91406e-05
|
|
|
ATCAY
|
[NCBI]
|
1.91406e-05
|
|
|
basal ganglia disease, adult-onset
|
[NCBI]
|
1.91406e-05
|
|
|
RP13
|
[NCBI]
|
1.91406e-05
|
|
|
DFNA20
|
[NCBI]
|
1.91406e-05
|
|
|
ceroid lipofuscinosis, neuronal, 8, northern epilepsy variant
|
[NCBI]
|
1.91406e-05
|
|
|
USH2C
|
[NCBI]
|
1.91406e-05
|
|
|
MRT1
|
[NCBI]
|
1.91406e-05
|
|
|
DFNB18
|
[NCBI]
|
1.91406e-05
|
|
|
CMD1E
|
[NCBI]
|
1.91406e-05
|
|
|
PPNAD1
|
[NCBI]
|
1.91406e-05
|
|
|
cherubism
|
[NCBI]
|
1.91406e-05
|
|
|
charcot-marie-tooth disease and deafness
|
[NCBI]
|
1.91406e-05
|
|
|
peters anomaly
|
[NCBI]
|
1.91406e-05
|
|
|
thrombophilia
|
[NCBI]
|
1.91406e-05
|
|
|
keratoderma, palmoplantar, with deafness
|
[NCBI]
|
1.91406e-05
|
|
|
alternating hemiplegia of childhood
|
[NCBI]
|
1.91406e-05
|
|
|
RP14
|
[NCBI]
|
1.91406e-05
|
|
|
hairy ears, y-linked
|
[NCBI]
|
1.91406e-05
|
|
|
PVOD
|
[NCBI]
|
1.91406e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2j
|
[NCBI]
|
1.91406e-05
|
|
|
BDNF
|
[NCBI]
|
1.90878e-05
|
|
|
ALDH2
|
[NCBI]
|
1.8954e-05
|
|
|
PMD
|
[NCBI]
|
1.87915e-05
|
|
|
AURKA
|
[NCBI]
|
1.87687e-05
|
|
|
EPM2A
|
[NCBI]
|
1.87687e-05
|
|
|
RS1
|
[NCBI]
|
1.85542e-05
|
|
|
RECQL2
|
[NCBI]
|
1.85542e-05
|
|
|
MEN2A
|
[NCBI]
|
1.85537e-05
|
|
|
CHAC
|
[NCBI]
|
1.84376e-05
|
|
|
PPH1
|
[NCBI]
|
1.84376e-05
|
|
|
DARS2
|
[NCBI]
|
1.82712e-05
|
|
|
SETDB2
|
[NCBI]
|
1.82712e-05
|
|
|
RARS2
|
[NCBI]
|
1.82712e-05
|
|
|
mei1, mouse, homolog of
|
[NCBI]
|
1.82712e-05
|
|
|
FCGR3B
|
[NCBI]
|
1.82712e-05
|
|
|
IAN4L1
|
[NCBI]
|
1.82712e-05
|
|
|
NDUFV3
|
[NCBI]
|
1.82712e-05
|
|
|
myeloid leukemia-related gene
|
[NCBI]
|
1.82712e-05
|
|
|
MED12L
|
[NCBI]
|
1.82712e-05
|
|
|
TBCD
|
[NCBI]
|
1.82712e-05
|
|
|
MMAA
|
[NCBI]
|
1.82712e-05
|
|
|
PGA3
|
[NCBI]
|
1.82712e-05
|
|
|
CTPP4
|
[NCBI]
|
1.82712e-05
|
|
|
NEURL
|
[NCBI]
|
1.82712e-05
|
|
|
CENTA2
|
[NCBI]
|
1.82712e-05
|
|
|
small membrane protein 1
|
[NCBI]
|
1.82712e-05
|
|
|
breast cancer cell 2
|
[NCBI]
|
1.82712e-05
|
|
|
kiaa0319 gene
|
[NCBI]
|
1.82712e-05
|
|
|
OVOL1
|
[NCBI]
|
1.82712e-05
|
|
|
HMX1
|
[NCBI]
|
1.82712e-05
|
|
|
HYLS1
|
[NCBI]
|
1.82712e-05
|
|
|
TMIE
|
[NCBI]
|
1.82712e-05
|
|
|
PACE4
|
[NCBI]
|
1.82712e-05
|
|
|
ichthyin
|
[NCBI]
|
1.82712e-05
|
|
|
TAS2R38
|
[NCBI]
|
1.82712e-05
|
|
|
SLC12A8
|
[NCBI]
|
1.82712e-05
|
|
|
pin2-interacting protein 1
|
[NCBI]
|
1.82712e-05
|
|
|
ZNF674
|
[NCBI]
|
1.82712e-05
|
|
|
IFI44
|
[NCBI]
|
1.82712e-05
|
|
|
LAPTM5
|
[NCBI]
|
1.82712e-05
|
|
|
abl interactor 2
|
[NCBI]
|
1.82712e-05
|
|
|
ZNF79
|
[NCBI]
|
1.82712e-05
|
|
|
DUSP12
|
[NCBI]
|
1.82712e-05
|
|
|
MYO5B
|
[NCBI]
|
1.82712e-05
|
|
|
GPR35
|
[NCBI]
|
1.82712e-05
|
|
|
GFPT2
|
[NCBI]
|
1.82712e-05
|
|
|
HNMT
|
[NCBI]
|
1.81664e-05
|
|
|
PKLR
|
[NCBI]
|
1.81664e-05
|
|
|
C4B
|
[NCBI]
|
1.81664e-05
|
|
|
RTT
|
[NCBI]
|
1.80678e-05
|
|
|
RAB27A
|
[NCBI]
|
1.80167e-05
|
|
|
TAP1
|
[NCBI]
|
1.80167e-05
|
|
|
SSTR5
|
[NCBI]
|
1.80167e-05
|
|
|
MYBPC3
|
[NCBI]
|
1.80167e-05
|
|
|
LIG4
|
[NCBI]
|
1.80167e-05
|
|
|
TNFRSF11A
|
[NCBI]
|
1.80167e-05
|
|
|
SPG3A
|
[NCBI]
|
1.80167e-05
|
|
|
CCKAR
|
[NCBI]
|
1.80167e-05
|
|
|
ME2
|
[NCBI]
|
1.80167e-05
|
|
|
POU5F1
|
[NCBI]
|
1.80167e-05
|
|
|
COCH
|
[NCBI]
|
1.80167e-05
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
1.786e-05
|
|
|
LPI
|
[NCBI]
|
1.786e-05
|
|
|
AMCN
|
[NCBI]
|
1.78198e-05
|
|
|
HPCX
|
[NCBI]
|
1.78198e-05
|
|
|
UMOD
|
[NCBI]
|
1.77902e-05
|
|
|
FY
|
[NCBI]
|
1.77902e-05
|
|
|
ARSA
|
[NCBI]
|
1.73757e-05
|
|
|
FGA
|
[NCBI]
|
1.73757e-05
|
|
|
AMY2A
|
[NCBI]
|
1.73178e-05
|
|
|
CYP1A2
|
[NCBI]
|
1.73178e-05
|
|
|
ELAC2
|
[NCBI]
|
1.73178e-05
|
|
|
LAMA2
|
[NCBI]
|
1.73178e-05
|
|
|
TPH1
|
[NCBI]
|
1.73178e-05
|
|
|
RAPSN
|
[NCBI]
|
1.73178e-05
|
|
|
SCN9A
|
[NCBI]
|
1.73178e-05
|
|
|
ADIPOR1
|
[NCBI]
|
1.73178e-05
|
|
|
DBA
|
[NCBI]
|
1.72822e-05
|
|
|
MLC
|
[NCBI]
|
1.71823e-05
|
|
|
CLN1
|
[NCBI]
|
1.71823e-05
|
|
|
diastrophic dysplasia
|
[NCBI]
|
1.71823e-05
|
|
|
hodgkin lymphoma
|
[NCBI]
|
1.71823e-05
|
|
|
USH2A
|
[NCBI]
|
1.71823e-05
|
|
|
TCRG
|
[NCBI]
|
1.70698e-05
|
|
|
CTLA4
|
[NCBI]
|
1.70698e-05
|
|
|
mucopolysaccharidosis type iva
|
[NCBI]
|
1.70698e-05
|
|
|
APOA1
|
[NCBI]
|
1.68895e-05
|
|
|
COL1A1
|
[NCBI]
|
1.6854e-05
|
|
|
ADIPOQ
|
[NCBI]
|
1.67246e-05
|
|
|
APOM
|
[NCBI]
|
1.66657e-05
|
|
|
RNASEL
|
[NCBI]
|
1.66657e-05
|
|
|
CRYBA1
|
[NCBI]
|
1.66657e-05
|
|
|
IL7R
|
[NCBI]
|
1.66657e-05
|
|
|
AHR
|
[NCBI]
|
1.65517e-05
|
|
|
FMO2
|
[NCBI]
|
1.6396e-05
|
|
|
HMS
|
[NCBI]
|
1.6396e-05
|
|
|
STHAG3
|
[NCBI]
|
1.6396e-05
|
|
|
hypotrichosis simplex of scalp
|
[NCBI]
|
1.6396e-05
|
|
|
F5F8D
|
[NCBI]
|
1.6396e-05
|
|
|
MCOPS9
|
[NCBI]
|
1.6396e-05
|
|
|
three m syndrome
|
[NCBI]
|
1.6396e-05
|
|
|
NEM2
|
[NCBI]
|
1.6396e-05
|
|
|
wolfram syndrome, mitochondrial form
|
[NCBI]
|
1.6396e-05
|
|
|
short stature, idiopathic, autosomal
|
[NCBI]
|
1.6396e-05
|
|
|
DSAP1
|
[NCBI]
|
1.6396e-05
|
|
|
CDG1C
|
[NCBI]
|
1.6396e-05
|
|
|
methylcobalamin deficiency, cblg type
|
[NCBI]
|
1.6396e-05
|
|
|
FHL2
|
[NCBI]
|
1.6396e-05
|
|
|
mental health wellness 2
|
[NCBI]
|
1.6396e-05
|
|
|
CCA2
|
[NCBI]
|
1.6396e-05
|
|
|
cardiomyopathy, dilated, with woolly hair and keratoderma
|
[NCBI]
|
1.6396e-05
|
|
|
polymicrogyria, bilateral frontoparietal
|
[NCBI]
|
1.6396e-05
|
|
|
naegeli syndrome
|
[NCBI]
|
1.6396e-05
|
|
|
SPMM
|
[NCBI]
|
1.6396e-05
|
|
|
CPVT
|
[NCBI]
|
1.6396e-05
|
|
|
CZP3
|
[NCBI]
|
1.6396e-05
|
|
|
hemochromatosis, neonatal
|
[NCBI]
|
1.6396e-05
|
|
|
LSFC
|
[NCBI]
|
1.6396e-05
|
|
|
ENG
|
[NCBI]
|
1.6389e-05
|
|
|
CYP17A1
|
[NCBI]
|
1.6389e-05
|
|
|
SPP1
|
[NCBI]
|
1.63752e-05
|
|
|
ACADM
|
[NCBI]
|
1.63731e-05
|
|
|
POMC
|
[NCBI]
|
1.63088e-05
|
|
|
TSHB
|
[NCBI]
|
1.60551e-05
|
|
|
SQSTM1
|
[NCBI]
|
1.60551e-05
|
|
|
CMM2
|
[NCBI]
|
1.60101e-05
|
|
|
osteoporosis
|
[NCBI]
|
1.60101e-05
|
|
|
PCOS1
|
[NCBI]
|
1.5959e-05
|
|
|
PKD1
|
[NCBI]
|
1.59543e-05
|
|
|
CDLS1
|
[NCBI]
|
1.56864e-05
|
|
|
STAT6
|
[NCBI]
|
1.55243e-05
|
|
|
SGCE
|
[NCBI]
|
1.54813e-05
|
|
|
FRAXE
|
[NCBI]
|
1.54813e-05
|
|
|
SPR
|
[NCBI]
|
1.54813e-05
|
|
|
PRKCG
|
[NCBI]
|
1.54813e-05
|
|
|
PCDH15
|
[NCBI]
|
1.54813e-05
|
|
|
ECM1
|
[NCBI]
|
1.54813e-05
|
|
|
ABCA1
|
[NCBI]
|
1.54346e-05
|
|
|
MYOZ2
|
[NCBI]
|
1.52283e-05
|
|
|
PADI3
|
[NCBI]
|
1.52283e-05
|
|
|
HS1BP3
|
[NCBI]
|
1.52283e-05
|
|
|
FXYD6
|
[NCBI]
|
1.52283e-05
|
|
|
NDUFA8
|
[NCBI]
|
1.52283e-05
|
|
|
TTBK2
|
[NCBI]
|
1.52283e-05
|
|
|
DMGDH
|
[NCBI]
|
1.52283e-05
|
|
|
STX5A
|
[NCBI]
|
1.52283e-05
|
|
|
NDUFS7
|
[NCBI]
|
1.52283e-05
|
|
|
DDX4
|
[NCBI]
|
1.52283e-05
|
|
|
MDFI
|
[NCBI]
|
1.52283e-05
|
|
|
PCDHA8
|
[NCBI]
|
1.52283e-05
|
|
|
MAGED2
|
[NCBI]
|
1.52283e-05
|
|
|
TLL1
|
[NCBI]
|
1.52283e-05
|
|
|
FCRL3
|
[NCBI]
|
1.52283e-05
|
|
|
AS3MT
|
[NCBI]
|
1.52283e-05
|
|
|
PCDHA10
|
[NCBI]
|
1.52283e-05
|
|
|
LHFPL5
|
[NCBI]
|
1.52283e-05
|
|
|
RBM17
|
[NCBI]
|
1.52283e-05
|
|
|
ADH6
|
[NCBI]
|
1.52283e-05
|
|
|
INA
|
[NCBI]
|
1.52283e-05
|
|
|
SEA
|
[NCBI]
|
1.52283e-05
|
|
|
acidic cluster protein, 33-kd
|
[NCBI]
|
1.52283e-05
|
|
|
ZNF239
|
[NCBI]
|
1.52283e-05
|
|
|
GPR78
|
[NCBI]
|
1.52283e-05
|
|
|
CUL5
|
[NCBI]
|
1.52283e-05
|
|
|
TPX1
|
[NCBI]
|
1.52283e-05
|
|
|
TLL2
|
[NCBI]
|
1.52283e-05
|
|
|
EVER2
|
[NCBI]
|
1.52283e-05
|
|
|
PCSK4
|
[NCBI]
|
1.52283e-05
|
|
|
SUCLA2
|
[NCBI]
|
1.52283e-05
|
|
|
ASCC3L1
|
[NCBI]
|
1.52283e-05
|
|
|
BARHL1
|
[NCBI]
|
1.52283e-05
|
|
|
OTOG
|
[NCBI]
|
1.52283e-05
|
|
|
TAAR6
|
[NCBI]
|
1.52283e-05
|
|
|
P2RX5
|
[NCBI]
|
1.52283e-05
|
|
|
DCTD
|
[NCBI]
|
1.52283e-05
|
|
|
ABHD5
|
[NCBI]
|
1.52283e-05
|
|
|
CYP2F1
|
[NCBI]
|
1.52283e-05
|
|
|
TMEM67
|
[NCBI]
|
1.52283e-05
|
|
|
SLC24A5
|
[NCBI]
|
1.52283e-05
|
|
|
GPR109A
|
[NCBI]
|
1.52283e-05
|
|
|
PADI1
|
[NCBI]
|
1.52283e-05
|
|
|
PADI2
|
[NCBI]
|
1.52283e-05
|
|
|
HSPA1B
|
[NCBI]
|
1.52283e-05
|
|
|
KIAA0513
|
[NCBI]
|
1.52283e-05
|
|
|
ATP1B3
|
[NCBI]
|
1.52283e-05
|
|
|
SAMD9
|
[NCBI]
|
1.52283e-05
|
|
|
SH3BP2
|
[NCBI]
|
1.52283e-05
|
|
|
TIMM8B
|
[NCBI]
|
1.52283e-05
|
|
|
MTTS2
|
[NCBI]
|
1.52283e-05
|
|
|
PPP3CC
|
[NCBI]
|
1.52283e-05
|
|
|
USP24
|
[NCBI]
|
1.52283e-05
|
|
|
HBG2
|
[NCBI]
|
1.51328e-05
|
|
|
CACNA1S
|
[NCBI]
|
1.49406e-05
|
|
|
udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase
|
[NCBI]
|
1.49406e-05
|
|
|
SFTPB
|
[NCBI]
|
1.49406e-05
|
|
|
NEB
|
[NCBI]
|
1.49406e-05
|
|
|
GAD2
|
[NCBI]
|
1.49406e-05
|
|
|
CFNS
|
[NCBI]
|
1.49138e-05
|
|
|
PBD
|
[NCBI]
|
1.49138e-05
|
|
|
central core disease of muscle
|
[NCBI]
|
1.49138e-05
|
|
|
NTRK1
|
[NCBI]
|
1.48386e-05
|
|
|
thyroid carcinoma, papillary
|
[NCBI]
|
1.48145e-05
|
|
|
CD
|
[NCBI]
|
1.47195e-05
|
|
|
ADA
|
[NCBI]
|
1.46633e-05
|
|
|
CLN3
|
[NCBI]
|
1.44297e-05
|
|
|
HR
|
[NCBI]
|
1.44297e-05
|
|
|
SLC2A1
|
[NCBI]
|
1.44297e-05
|
|
|
CPT2
|
[NCBI]
|
1.44297e-05
|
|
|
SMAX1
|
[NCBI]
|
1.44186e-05
|
|
|
DAO
|
[NCBI]
|
1.42717e-05
|
|
|
PIL
|
[NCBI]
|
1.41343e-05
|
|
|
CHED2
|
[NCBI]
|
1.41343e-05
|
|
|
takayasu arteritis
|
[NCBI]
|
1.41343e-05
|
|
|
PHA2
|
[NCBI]
|
1.41343e-05
|
|
|
DYT12
|
[NCBI]
|
1.41343e-05
|
|
|
PARK7
|
[NCBI]
|
1.41343e-05
|
|
|
CDG1B
|
[NCBI]
|
1.41343e-05
|
|
|
mast cell disease
|
[NCBI]
|
1.41343e-05
|
|
|
PGL4
|
[NCBI]
|
1.41343e-05
|
|
|
psoriatic arthritis, susceptibility to
|
[NCBI]
|
1.41343e-05
|
|
|
kuru, susceptibility to
|
[NCBI]
|
1.41343e-05
|
|
|
IBMPFD
|
[NCBI]
|
1.41343e-05
|
|
|
ACHM3
|
[NCBI]
|
1.41343e-05
|
|
|
char syndrome
|
[NCBI]
|
1.41343e-05
|
|
|
AITD3
|
[NCBI]
|
1.41343e-05
|
|
|
EVR2
|
[NCBI]
|
1.41343e-05
|
|
|
citrullinemia, type ii, neonatal-onset
|
[NCBI]
|
1.41343e-05
|
|
|
MFS2
|
[NCBI]
|
1.41343e-05
|
|
|
myopathy, myosin storage
|
[NCBI]
|
1.41343e-05
|
|
|
globozoospermia
|
[NCBI]
|
1.41343e-05
|
|
|
ehlers-danlos syndrome, type iii
|
[NCBI]
|
1.41343e-05
|
|
|
vacterl association with hydrocephalus, x-linked
|
[NCBI]
|
1.41343e-05
|
|
|
RP10
|
[NCBI]
|
1.41343e-05
|
|
|
ODG2
|
[NCBI]
|
1.41343e-05
|
|
|
MDC1C
|
[NCBI]
|
1.41343e-05
|
|
|
mal de meleda
|
[NCBI]
|
1.41343e-05
|
|
|
cryptorchidism, unilateral or bilateral
|
[NCBI]
|
1.41343e-05
|
|
|
BPP
|
[NCBI]
|
1.41343e-05
|
|
|
hypertriglyceridemia, familial
|
[NCBI]
|
1.41343e-05
|
|
|
DFNB3
|
[NCBI]
|
1.41343e-05
|
|
|
epiphyseal dysplasia, multiple, with early-onset diabetes mellitus
|
[NCBI]
|
1.41343e-05
|
|
|
ZS
|
[NCBI]
|
1.41283e-05
|
|
|
NPS
|
[NCBI]
|
1.40883e-05
|
|
|
FOXC2
|
[NCBI]
|
1.3946e-05
|
|
|
FTD
|
[NCBI]
|
1.38909e-05
|
|
|
DYX1
|
[NCBI]
|
1.38872e-05
|
|
|
FXN
|
[NCBI]
|
1.37318e-05
|
|
|
NKX2-1
|
[NCBI]
|
1.34869e-05
|
|
|
MRE11A
|
[NCBI]
|
1.34869e-05
|
|
|
PLAT
|
[NCBI]
|
1.34869e-05
|
|
|
TCOF1
|
[NCBI]
|
1.34869e-05
|
|
|
GJB3
|
[NCBI]
|
1.34869e-05
|
|
|
RPE65
|
[NCBI]
|
1.34869e-05
|
|
|
LAMB3
|
[NCBI]
|
1.34869e-05
|
|
|
MVP
|
[NCBI]
|
1.34629e-05
|
|
|
RP
|
[NCBI]
|
1.34229e-05
|
|
|
MPZ
|
[NCBI]
|
1.33337e-05
|
|
|
DNMBP
|
[NCBI]
|
1.32769e-05
|
|
|
AOC2
|
[NCBI]
|
1.32769e-05
|
|
|
pejvakin
|
[NCBI]
|
1.32769e-05
|
|
|
PCSK5
|
[NCBI]
|
1.32769e-05
|
|
|
HCCS
|
[NCBI]
|
1.32769e-05
|
|
|
SLC6A14
|
[NCBI]
|
1.32769e-05
|
|
|
NDUFB6
|
[NCBI]
|
1.32769e-05
|
|
|
BBS2
|
[NCBI]
|
1.32769e-05
|
|
|
TAGLN2
|
[NCBI]
|
1.32769e-05
|
|
|
BTBD9
|
[NCBI]
|
1.32769e-05
|
|
|
LEMD3
|
[NCBI]
|
1.32769e-05
|
|
|
EVER1
|
[NCBI]
|
1.32769e-05
|
|
|
ZNF350
|
[NCBI]
|
1.32769e-05
|
|
|
COL8A2
|
[NCBI]
|
1.32769e-05
|
|
|
SOX21
|
[NCBI]
|
1.32769e-05
|
|
|
NKX2-6
|
[NCBI]
|
1.32769e-05
|
|
|
TSNAX
|
[NCBI]
|
1.32769e-05
|
|
|
PLK4
|
[NCBI]
|
1.32769e-05
|
|
|
MUC7
|
[NCBI]
|
1.32769e-05
|
|
|
RDH8
|
[NCBI]
|
1.32769e-05
|
|
|
CTDP1
|
[NCBI]
|
1.32769e-05
|
|
|
CLK2
|
[NCBI]
|
1.32769e-05
|
|
|
PSMA6
|
[NCBI]
|
1.32769e-05
|
|
|
SLC28A3
|
[NCBI]
|
1.32769e-05
|
|
|
CCDC50
|
[NCBI]
|
1.32769e-05
|
|
|
PHF11
|
[NCBI]
|
1.32769e-05
|
|
|
CENPF
|
[NCBI]
|
1.32769e-05
|
|
|
ALOXE3
|
[NCBI]
|
1.32769e-05
|
|
|
KIR2DL5
|
[NCBI]
|
1.32769e-05
|
|
|
PFN2
|
[NCBI]
|
1.32769e-05
|
|
|
CENPI
|
[NCBI]
|
1.32769e-05
|
|
|
ITGA7
|
[NCBI]
|
1.32769e-05
|
|
|
ANGPTL2
|
[NCBI]
|
1.32769e-05
|
|
|
COLEC12
|
[NCBI]
|
1.32769e-05
|
|
|
ITPR3
|
[NCBI]
|
1.32769e-05
|
|
|
SNAP29
|
[NCBI]
|
1.32769e-05
|
|
|
IL1R2
|
[NCBI]
|
1.32769e-05
|
|
|
CLINT1
|
[NCBI]
|
1.32769e-05
|
|
|
FKBP6
|
[NCBI]
|
1.32769e-05
|
|
|
C1QTNF5
|
[NCBI]
|
1.32769e-05
|
|
|
CHGB
|
[NCBI]
|
1.32769e-05
|
|
|
TNNI1
|
[NCBI]
|
1.32769e-05
|
|
|
TPST1
|
[NCBI]
|
1.32769e-05
|
|
|
WWC1
|
[NCBI]
|
1.32769e-05
|
|
|
SNX15
|
[NCBI]
|
1.32769e-05
|
|
|
OAZ3
|
[NCBI]
|
1.32769e-05
|
|
|
RASSF5
|
[NCBI]
|
1.32769e-05
|
|
|
SLC12A6
|
[NCBI]
|
1.32769e-05
|
|
|
HSPE1
|
[NCBI]
|
1.32769e-05
|
|
|
STRA6
|
[NCBI]
|
1.32769e-05
|
|
|
CFHR3
|
[NCBI]
|
1.32769e-05
|
|
|
NEF3
|
[NCBI]
|
1.32769e-05
|
|
|
TRPM6
|
[NCBI]
|
1.32769e-05
|
|
|
CH25H
|
[NCBI]
|
1.32769e-05
|
|
|
CHRM2
|
[NCBI]
|
1.32769e-05
|
|
|
GPNMB
|
[NCBI]
|
1.32769e-05
|
|
|
GPR34
|
[NCBI]
|
1.32769e-05
|
|
|
RPL12
|
[NCBI]
|
1.32769e-05
|
|
|
HOXD4
|
[NCBI]
|
1.32769e-05
|
|
|
UROS
|
[NCBI]
|
1.30503e-05
|
|
|
TGFBI
|
[NCBI]
|
1.30503e-05
|
|
|
MSX1
|
[NCBI]
|
1.30503e-05
|
|
|
DFNB1
|
[NCBI]
|
1.2925e-05
|
|
|
NAT1
|
[NCBI]
|
1.27252e-05
|
|
|
MYO5A
|
[NCBI]
|
1.26345e-05
|
|
|
CRP
|
[NCBI]
|
1.26345e-05
|
|
|
SLC3A1
|
[NCBI]
|
1.26345e-05
|
|
|
IGF2
|
[NCBI]
|
1.24875e-05
|
|
|
ALB
|
[NCBI]
|
1.24399e-05
|
|
|
pta deficiency
|
[NCBI]
|
1.22377e-05
|
|
|
MTND2
|
[NCBI]
|
1.22377e-05
|
|
|
PLSJ
|
[NCBI]
|
1.22337e-05
|
|
|
VLDLRCH
|
[NCBI]
|
1.22337e-05
|
|
|
fundus albipunctatus
|
[NCBI]
|
1.22337e-05
|
|
|
epidermolysis bullosa dystrophica, pasini type
|
[NCBI]
|
1.22337e-05
|
|
|
gitelman syndrome
|
[NCBI]
|
1.22337e-05
|
|
|
OCA3
|
[NCBI]
|
1.22337e-05
|
|
|
GS2
|
[NCBI]
|
1.22337e-05
|
|
|
EDM4
|
[NCBI]
|
1.22337e-05
|
|
|
caffey disease
|
[NCBI]
|
1.22337e-05
|
|
|
hyperlipidemia, combined, 1
|
[NCBI]
|
1.22337e-05
|
|
|
DFNA3
|
[NCBI]
|
1.22337e-05
|
|
|
RP12
|
[NCBI]
|
1.22337e-05
|
|
|
DFNA9
|
[NCBI]
|
1.22337e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, lethal neonatal
|
[NCBI]
|
1.22337e-05
|
|
|
corticosteroid-binding globulin deficiency
|
[NCBI]
|
1.22337e-05
|
|
|
usher syndrome, type i
|
[NCBI]
|
1.20221e-05
|
|
|
DAR
|
[NCBI]
|
1.20221e-05
|
|
|
LMNA
|
[NCBI]
|
1.19508e-05
|
|
|
COL4A3
|
[NCBI]
|
1.18586e-05
|
|
|
ATF6
|
[NCBI]
|
1.18586e-05
|
|
|
CTSK
|
[NCBI]
|
1.18586e-05
|
|
|
ATXN8OS
|
[NCBI]
|
1.18586e-05
|
|
|
PTGDR
|
[NCBI]
|
1.18439e-05
|
|
|
LILRA2
|
[NCBI]
|
1.18439e-05
|
|
|
SLC25A19
|
[NCBI]
|
1.18439e-05
|
|
|
IL10RA
|
[NCBI]
|
1.18439e-05
|
|
|
CPT1B
|
[NCBI]
|
1.18439e-05
|
|
|
GPR44
|
[NCBI]
|
1.18439e-05
|
|
|
ZDHHC8
|
[NCBI]
|
1.18439e-05
|
|
|
GLMN
|
[NCBI]
|
1.18439e-05
|
|
|
STK19
|
[NCBI]
|
1.18439e-05
|
|
|
PMP2
|
[NCBI]
|
1.18439e-05
|
|
|
TGM5
|
[NCBI]
|
1.18439e-05
|
|
|
STRC
|
[NCBI]
|
1.18439e-05
|
|
|
NDUFV1
|
[NCBI]
|
1.18439e-05
|
|
|
KCNC3
|
[NCBI]
|
1.18439e-05
|
|
|
ABCA12
|
[NCBI]
|
1.18439e-05
|
|
|
ACTR1A
|
[NCBI]
|
1.18439e-05
|
|
|
saitohin
|
[NCBI]
|
1.18439e-05
|
|
|
GPR74
|
[NCBI]
|
1.18439e-05
|
|
|
CDKAL1
|
[NCBI]
|
1.18439e-05
|
|
|
MX1
|
[NCBI]
|
1.18439e-05
|
|
|
IRAK3
|
[NCBI]
|
1.18439e-05
|
|
|
MMP20
|
[NCBI]
|
1.18439e-05
|
|
|
PIP5K3
|
[NCBI]
|
1.18439e-05
|
|
|
YARS
|
[NCBI]
|
1.18439e-05
|
|
|
CATSPER2
|
[NCBI]
|
1.18439e-05
|
|
|
PCDHA9
|
[NCBI]
|
1.18439e-05
|
|
|
ADH7
|
[NCBI]
|
1.18439e-05
|
|
|
PLXNA2
|
[NCBI]
|
1.18439e-05
|
|
|
GABRA6
|
[NCBI]
|
1.18439e-05
|
|
|
NCR3
|
[NCBI]
|
1.18439e-05
|
|
|
MSC
|
[NCBI]
|
1.18439e-05
|
|
|
PRSS2
|
[NCBI]
|
1.18439e-05
|
|
|
CRYGS
|
[NCBI]
|
1.18439e-05
|
|
|
CYSLTR2
|
[NCBI]
|
1.18439e-05
|
|
|
BFSP1
|
[NCBI]
|
1.18439e-05
|
|
|
COMMD1
|
[NCBI]
|
1.18439e-05
|
|
|
ITIH2
|
[NCBI]
|
1.18439e-05
|
|
|
GPR109B
|
[NCBI]
|
1.18439e-05
|
|
|
EFEMP1
|
[NCBI]
|
1.18439e-05
|
|
|
SLC7A8
|
[NCBI]
|
1.18439e-05
|
|
|
PACRG
|
[NCBI]
|
1.18439e-05
|
|
|
NPR1
|
[NCBI]
|
1.18439e-05
|
|
|
PLA2G6
|
[NCBI]
|
1.18439e-05
|
|
|
VAPB
|
[NCBI]
|
1.18439e-05
|
|
|
CUL7
|
[NCBI]
|
1.18439e-05
|
|
|
MTND4
|
[NCBI]
|
1.18052e-05
|
|
|
TYR
|
[NCBI]
|
1.17887e-05
|
|
|
HMBS
|
[NCBI]
|
1.17482e-05
|
|
|
CHRNE
|
[NCBI]
|
1.14959e-05
|
|
|
GJA8
|
[NCBI]
|
1.14959e-05
|
|
|
SMA1
|
[NCBI]
|
1.14763e-05
|
|
|
CYP19A1
|
[NCBI]
|
1.13742e-05
|
|
|
STGD1
|
[NCBI]
|
1.11744e-05
|
|
|
CPB2
|
[NCBI]
|
1.11625e-05
|
|
|
TAF1
|
[NCBI]
|
1.11483e-05
|
|
|
STAT3
|
[NCBI]
|
1.10282e-05
|
|
|
ELN
|
[NCBI]
|
1.0961e-05
|
|
|
PEE1
|
[NCBI]
|
1.0897e-05
|
|
|
PROS1
|
[NCBI]
|
1.0815e-05
|
|
|
NOS2A
|
[NCBI]
|
1.0815e-05
|
|
|
IL6
|
[NCBI]
|
1.07585e-05
|
|
|
RTN3
|
[NCBI]
|
1.07161e-05
|
|
|
SLC29A2
|
[NCBI]
|
1.07161e-05
|
|
|
PLOD3
|
[NCBI]
|
1.07161e-05
|
|
|
SYN2
|
[NCBI]
|
1.07161e-05
|
|
|
MYL3
|
[NCBI]
|
1.07161e-05
|
|
|
PADI4
|
[NCBI]
|
1.07161e-05
|
|
|
GABRA2
|
[NCBI]
|
1.07161e-05
|
|
|
COPA
|
[NCBI]
|
1.07161e-05
|
|
|
SYT3
|
[NCBI]
|
1.07161e-05
|
|
|
MOCS1
|
[NCBI]
|
1.07161e-05
|
|
|
NLRP7
|
[NCBI]
|
1.07161e-05
|
|
|
PON3
|
[NCBI]
|
1.07161e-05
|
|
|
NPHP3
|
[NCBI]
|
1.07161e-05
|
|
|
NHEJ1
|
[NCBI]
|
1.07161e-05
|
|
|
precursor mrna-processing factor 3, s. cerevisiae, homolog of
|
[NCBI]
|
1.07161e-05
|
|
|
PLUNC
|
[NCBI]
|
1.07161e-05
|
|
|
CES2
|
[NCBI]
|
1.07161e-05
|
|
|
ALPPL2
|
[NCBI]
|
1.07161e-05
|
|
|
SLC22A3
|
[NCBI]
|
1.07161e-05
|
|
|
DLX3
|
[NCBI]
|
1.07161e-05
|
|
|
MYO9B
|
[NCBI]
|
1.07161e-05
|
|
|
NTF5
|
[NCBI]
|
1.07161e-05
|
|
|
TACR2
|
[NCBI]
|
1.07161e-05
|
|
|
GJC2
|
[NCBI]
|
1.07161e-05
|
|
|
CMA1
|
[NCBI]
|
1.07161e-05
|
|
|
E2F2
|
[NCBI]
|
1.07161e-05
|
|
|
DEFB103A
|
[NCBI]
|
1.07161e-05
|
|
|
CDAN1
|
[NCBI]
|
1.07161e-05
|
|
|
bsnd gene
|
[NCBI]
|
1.07161e-05
|
|
|
ALG6
|
[NCBI]
|
1.07161e-05
|
|
|
DLG5
|
[NCBI]
|
1.07161e-05
|
|
|
MLX
|
[NCBI]
|
1.07161e-05
|
|
|
SBF2
|
[NCBI]
|
1.07161e-05
|
|
|
KIF5A
|
[NCBI]
|
1.07161e-05
|
|
|
IGHD
|
[NCBI]
|
1.07161e-05
|
|
|
switch-associated protein 70
|
[NCBI]
|
1.07161e-05
|
|
|
regulatory associated protein of mtor
|
[NCBI]
|
1.07161e-05
|
|
|
TBX19
|
[NCBI]
|
1.07161e-05
|
|
|
RFXANK
|
[NCBI]
|
1.07161e-05
|
|
|
NDST2
|
[NCBI]
|
1.07161e-05
|
|
|
CASP12
|
[NCBI]
|
1.07161e-05
|
|
|
GJB4
|
[NCBI]
|
1.07161e-05
|
|
|
KIR2DL2
|
[NCBI]
|
1.07161e-05
|
|
|
ARL6
|
[NCBI]
|
1.07161e-05
|
|
|
PI7
|
[NCBI]
|
1.07161e-05
|
|
|
ALOX12B
|
[NCBI]
|
1.07161e-05
|
|
|
IMPA2
|
[NCBI]
|
1.07161e-05
|
|
|
KIF11
|
[NCBI]
|
1.07161e-05
|
|
|
NDUFS1
|
[NCBI]
|
1.07161e-05
|
|
|
MSH5
|
[NCBI]
|
1.07161e-05
|
|
|
BBS1
|
[NCBI]
|
1.07161e-05
|
|
|
CRMP1
|
[NCBI]
|
1.07161e-05
|
|
|
SEC23A
|
[NCBI]
|
1.07161e-05
|
|
|
17-@beta hydroxysteroid dehydrogenase iii deficiency
|
[NCBI]
|
1.06132e-05
|
|
|
LISX1
|
[NCBI]
|
1.06132e-05
|
|
|
hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
|
[NCBI]
|
1.06132e-05
|
|
|
alzheimer disease 4
|
[NCBI]
|
1.06132e-05
|
|
|
kindler syndrome
|
[NCBI]
|
1.06132e-05
|
|
|
corneal dystrophy, gelatinous drop-like
|
[NCBI]
|
1.06132e-05
|
|
|
epstein syndrome
|
[NCBI]
|
1.06132e-05
|
|
|
CTLN2
|
[NCBI]
|
1.06132e-05
|
|
|
WZS
|
[NCBI]
|
1.06132e-05
|
|
|
MCPH5
|
[NCBI]
|
1.06132e-05
|
|
|
stuve-wiedemann syndrome
|
[NCBI]
|
1.06132e-05
|
|
|
SXI1
|
[NCBI]
|
1.06132e-05
|
|
|
DA1
|
[NCBI]
|
1.06132e-05
|
|
|
LPL
|
[NCBI]
|
1.05433e-05
|
|
|
NPC1
|
[NCBI]
|
1.04948e-05
|
|
|
APOH
|
[NCBI]
|
1.04948e-05
|
|
|
CSTB
|
[NCBI]
|
1.04948e-05
|
|
|
BLM
|
[NCBI]
|
1.04218e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
1.04218e-05
|
|
|
LS
|
[NCBI]
|
1.04218e-05
|
|
|
hypophosphatasia, infantile
|
[NCBI]
|
1.03778e-05
|
|
|
ERCC2
|
[NCBI]
|
1.01871e-05
|
|
|
MEFV
|
[NCBI]
|
1.01871e-05
|
|
|
CETP
|
[NCBI]
|
1.01871e-05
|
|
|
SMAD4
|
[NCBI]
|
1.01871e-05
|
|
|
MTRNR1
|
[NCBI]
|
1.01871e-05
|
|
|
GJA1
|
[NCBI]
|
1.01699e-05
|
|
|
MAOB
|
[NCBI]
|
9.89101e-06
|
|
|
FASN
|
[NCBI]
|
9.89101e-06
|
|
|
IL8
|
[NCBI]
|
9.89101e-06
|
|
|
MTND5
|
[NCBI]
|
9.89101e-06
|
|
|
CAPN1
|
[NCBI]
|
9.7901e-06
|
|
|
XRCC3
|
[NCBI]
|
9.7901e-06
|
|
|
TPM2
|
[NCBI]
|
9.7901e-06
|
|
|
PMX1
|
[NCBI]
|
9.7901e-06
|
|
|
CHD7
|
[NCBI]
|
9.7901e-06
|
|
|
SP110
|
[NCBI]
|
9.7901e-06
|
|
|
TAS2R10
|
[NCBI]
|
9.7901e-06
|
|
|
CCL7
|
[NCBI]
|
9.7901e-06
|
|
|
MEOX1
|
[NCBI]
|
9.7901e-06
|
|
|
CTNNA2
|
[NCBI]
|
9.7901e-06
|
|
|
TLR10
|
[NCBI]
|
9.7901e-06
|
|
|
HRPT2
|
[NCBI]
|
9.7901e-06
|
|
|
SLC30A8
|
[NCBI]
|
9.7901e-06
|
|
|
WISP3
|
[NCBI]
|
9.7901e-06
|
|
|
HSPB8
|
[NCBI]
|
9.7901e-06
|
|
|
SATB2
|
[NCBI]
|
9.7901e-06
|
|
|
XCE
|
[NCBI]
|
9.7901e-06
|
|
|
TSN
|
[NCBI]
|
9.7901e-06
|
|
|
MMP8
|
[NCBI]
|
9.7901e-06
|
|
|
NHLH1
|
[NCBI]
|
9.7901e-06
|
|
|
CDKN2C
|
[NCBI]
|
9.7901e-06
|
|
|
RFC1
|
[NCBI]
|
9.7901e-06
|
|
|
ADIPOR2
|
[NCBI]
|
9.7901e-06
|
|
|
HSF4
|
[NCBI]
|
9.7901e-06
|
|
|
NDUFS8
|
[NCBI]
|
9.7901e-06
|
|
|
AIF1
|
[NCBI]
|
9.7901e-06
|
|
|
TCF8
|
[NCBI]
|
9.7901e-06
|
|
|
IGF2BP2
|
[NCBI]
|
9.7901e-06
|
|
|
WHRN
|
[NCBI]
|
9.7901e-06
|
|
|
NHLRC1
|
[NCBI]
|
9.7901e-06
|
|
|
TNNT1
|
[NCBI]
|
9.7901e-06
|
|
|
IL1R1
|
[NCBI]
|
9.7901e-06
|
|
|
CHMP4B
|
[NCBI]
|
9.7901e-06
|
|
|
IL1RAPL1
|
[NCBI]
|
9.7901e-06
|
|
|
SART3
|
[NCBI]
|
9.7901e-06
|
|
|
FOXJ1
|
[NCBI]
|
9.7901e-06
|
|
|
NPEPPS
|
[NCBI]
|
9.7901e-06
|
|
|
NS1
|
[NCBI]
|
9.71724e-06
|
|
|
PMCH
|
[NCBI]
|
9.58695e-06
|
|
|
MODY3
|
[NCBI]
|
9.21666e-06
|
|
|
ATS
|
[NCBI]
|
9.21666e-06
|
|
|
RP11
|
[NCBI]
|
9.21666e-06
|
|
|
ASMD
|
[NCBI]
|
9.21666e-06
|
|
|
cirrhosis, familial
|
[NCBI]
|
9.21666e-06
|
|
|
ehlers-danlos syndrome, type ii
|
[NCBI]
|
9.21666e-06
|
|
|
phosphoglycerate kinase 1 deficiency
|
[NCBI]
|
9.21666e-06
|
|
|
CDL1
|
[NCBI]
|
9.21666e-06
|
|
|
gracile syndrome
|
[NCBI]
|
9.21666e-06
|
|
|
CMT2A2
|
[NCBI]
|
9.21666e-06
|
|
|
BDC
|
[NCBI]
|
9.21666e-06
|
|
|
IRID1
|
[NCBI]
|
9.21666e-06
|
|
|
SPG6
|
[NCBI]
|
9.21666e-06
|
|
|
SCAR1
|
[NCBI]
|
9.21666e-06
|
|
|
BOS1
|
[NCBI]
|
9.21666e-06
|
|
|
GVM
|
[NCBI]
|
9.21666e-06
|
|
|
brody myopathy
|
[NCBI]
|
9.21666e-06
|
|
|
OSMED
|
[NCBI]
|
9.21666e-06
|
|
|
SCZD2
|
[NCBI]
|
9.21666e-06
|
|
|
GINGF
|
[NCBI]
|
9.21666e-06
|
|
|
hydrolethalus syndrome 1
|
[NCBI]
|
9.21666e-06
|
|
|
scheie syndrome
|
[NCBI]
|
9.21666e-06
|
|
|
ichthyosis vulgaris
|
[NCBI]
|
9.21666e-06
|
|
|
TPMT
|
[NCBI]
|
9.09233e-06
|
|
|
LRP1
|
[NCBI]
|
9.06251e-06
|
|
|
RNU2
|
[NCBI]
|
9.00746e-06
|
|
|
TBX4
|
[NCBI]
|
9.00746e-06
|
|
|
S100A7
|
[NCBI]
|
9.00746e-06
|
|
|
CAMK2G
|
[NCBI]
|
9.00746e-06
|
|
|
IL8RA
|
[NCBI]
|
9.00746e-06
|
|
|
ADRA2A
|
[NCBI]
|
9.00746e-06
|
|
|
PTGFR
|
[NCBI]
|
9.00746e-06
|
|
|
COL9A3
|
[NCBI]
|
9.00746e-06
|
|
|
HSD17B1
|
[NCBI]
|
9.00746e-06
|
|
|
TMPRSS3
|
[NCBI]
|
9.00746e-06
|
|
|
TM4SF2
|
[NCBI]
|
9.00746e-06
|
|
|
TAC1
|
[NCBI]
|
9.00746e-06
|
|
|
FSCN2
|
[NCBI]
|
9.00746e-06
|
|
|
PSTPIP1
|
[NCBI]
|
9.00746e-06
|
|
|
DCLRE1C
|
[NCBI]
|
9.00746e-06
|
|
|
OPRK1
|
[NCBI]
|
9.00746e-06
|
|
|
SLC39A4
|
[NCBI]
|
9.00746e-06
|
|
|
FUT6
|
[NCBI]
|
9.00746e-06
|
|
|
LGR8
|
[NCBI]
|
9.00746e-06
|
|
|
CSRP1
|
[NCBI]
|
9.00746e-06
|
|
|
ALX4
|
[NCBI]
|
9.00746e-06
|
|
|
WNT3
|
[NCBI]
|
9.00746e-06
|
|
|
BAT1
|
[NCBI]
|
9.00746e-06
|
|
|
GSTA2
|
[NCBI]
|
9.00746e-06
|
|
|
NT5C3
|
[NCBI]
|
9.00746e-06
|
|
|
tl antigen
|
[NCBI]
|
9.00746e-06
|
|
|
SLC7A7
|
[NCBI]
|
9.00746e-06
|
|
|
HMMR
|
[NCBI]
|
9.00746e-06
|
|
|
HES1
|
[NCBI]
|
9.00746e-06
|
|
|
KIF1B
|
[NCBI]
|
9.00746e-06
|
|
|
CNGA3
|
[NCBI]
|
9.00746e-06
|
|
|
cystinuria
|
[NCBI]
|
8.92483e-06
|
|
|
AVPR2
|
[NCBI]
|
8.80998e-06
|
|
|
PRPH2
|
[NCBI]
|
8.80998e-06
|
|
|
HBG1
|
[NCBI]
|
8.79988e-06
|
|
|
SLOS
|
[NCBI]
|
8.7551e-06
|
|
|
CCD
|
[NCBI]
|
8.68634e-06
|
|
|
PI
|
[NCBI]
|
8.5664e-06
|
|
|
FOXO1A
|
[NCBI]
|
8.56276e-06
|
|
|
MTTL1
|
[NCBI]
|
8.48539e-06
|
|
|
TSHR
|
[NCBI]
|
8.48539e-06
|
|
|
AS
|
[NCBI]
|
8.40049e-06
|
|
|
GCKR
|
[NCBI]
|
8.33202e-06
|
|
|
VIL
|
[NCBI]
|
8.33202e-06
|
|
|
SLC2A8
|
[NCBI]
|
8.33202e-06
|
|
|
CRLF1
|
[NCBI]
|
8.33202e-06
|
|
|
SIP1
|
[NCBI]
|
8.33202e-06
|
|
|
CHX10
|
[NCBI]
|
8.33202e-06
|
|
|
CFHR1
|
[NCBI]
|
8.33202e-06
|
|
|
CD74
|
[NCBI]
|
8.33202e-06
|
|
|
NRG2
|
[NCBI]
|
8.33202e-06
|
|
|
BCKDHB
|
[NCBI]
|
8.33202e-06
|
|
|
ADRA1B
|
[NCBI]
|
8.33202e-06
|
|
|
CHRD
|
[NCBI]
|
8.33202e-06
|
|
|
IL21R
|
[NCBI]
|
8.33202e-06
|
|
|
ARHGEF6
|
[NCBI]
|
8.33202e-06
|
|
|
NOTCH4
|
[NCBI]
|
8.33202e-06
|
|
|
MYLK
|
[NCBI]
|
8.33202e-06
|
|
|
CHRND
|
[NCBI]
|
8.33202e-06
|
|
|
PTF1A
|
[NCBI]
|
8.33202e-06
|
|
|
SIRT3
|
[NCBI]
|
8.33202e-06
|
|
|
FRZB
|
[NCBI]
|
8.33202e-06
|
|
|
SEMA7A
|
[NCBI]
|
8.33202e-06
|
|
|
ABCG8
|
[NCBI]
|
8.33202e-06
|
|
|
CCKBR
|
[NCBI]
|
8.33202e-06
|
|
|
GAB2
|
[NCBI]
|
8.33202e-06
|
|
|
TOP3A
|
[NCBI]
|
8.33202e-06
|
|
|
CD3D
|
[NCBI]
|
8.33202e-06
|
|
|
OPHN1
|
[NCBI]
|
8.33202e-06
|
|
|
GRIK1
|
[NCBI]
|
8.33202e-06
|
|
|
PRLHR
|
[NCBI]
|
8.33202e-06
|
|
|
AHI1
|
[NCBI]
|
8.33202e-06
|
|
|
SEMA5A
|
[NCBI]
|
8.33202e-06
|
|
|
DR1
|
[NCBI]
|
8.33202e-06
|
|
|
CITED2
|
[NCBI]
|
8.33202e-06
|
|
|
MTRR
|
[NCBI]
|
8.33202e-06
|
|
|
TEK
|
[NCBI]
|
8.33202e-06
|
|
|
hemojuvelin
|
[NCBI]
|
8.33202e-06
|
|
|
ACTN3
|
[NCBI]
|
8.33202e-06
|
|
|
DNASE1
|
[NCBI]
|
8.33202e-06
|
|
|
SHOX
|
[NCBI]
|
8.32379e-06
|
|
|
TPI1
|
[NCBI]
|
8.32379e-06
|
|
|
SOD2
|
[NCBI]
|
8.26656e-06
|
|
|
MKS1
|
[NCBI]
|
8.24406e-06
|
|
|
ARMD1
|
[NCBI]
|
8.24406e-06
|
|
|
BCHE
|
[NCBI]
|
8.23508e-06
|
|
|
MTR
|
[NCBI]
|
8.18221e-06
|
|
|
RHCE
|
[NCBI]
|
8.09265e-06
|
|
|
AGTR1
|
[NCBI]
|
8.09265e-06
|
|
|
GPI
|
[NCBI]
|
8.03061e-06
|
|
|
MRXS13
|
[NCBI]
|
8.00307e-06
|
|
|
von willebrand disease, recessive form
|
[NCBI]
|
8.00307e-06
|
|
|
gaucher disease, type ii
|
[NCBI]
|
8.00307e-06
|
|
|
mitochondrial dna depletion syndrome, myopathic form
|
[NCBI]
|
8.00307e-06
|
|
|
MTC
|
[NCBI]
|
8.00307e-06
|
|
|
leiomyoma, hereditary multiple, of skin
|
[NCBI]
|
8.00307e-06
|
|
|
CDA
|
[NCBI]
|
8.00307e-06
|
|
|
HOMG
|
[NCBI]
|
8.00307e-06
|
|
|
ALUNC
|
[NCBI]
|
8.00307e-06
|
|
|
LGMD2D
|
[NCBI]
|
8.00307e-06
|
|
|
methylmalonic aciduria and homocystinuria, cblc type
|
[NCBI]
|
8.00307e-06
|
|
|
SEDT
|
[NCBI]
|
8.00307e-06
|
|
|
HRPT2
|
[NCBI]
|
8.00307e-06
|
|
|
DA2B
|
[NCBI]
|
8.00307e-06
|
|
|
SNDI
|
[NCBI]
|
8.00307e-06
|
|
|
lipoid proteinosis of urbach and wiethe
|
[NCBI]
|
8.00307e-06
|
|
|
pycnodysostosis
|
[NCBI]
|
8.00307e-06
|
|
|
MTHFR
|
[NCBI]
|
7.88978e-06
|
|
|
GRN
|
[NCBI]
|
7.86895e-06
|
|
|
TRPC6
|
[NCBI]
|
7.7398e-06
|
|
|
SHANK3
|
[NCBI]
|
7.7398e-06
|
|
|
FZD4
|
[NCBI]
|
7.7398e-06
|
|
|
SYN1
|
[NCBI]
|
7.7398e-06
|
|
|
SCN1B
|
[NCBI]
|
7.7398e-06
|
|
|
BBS4
|
[NCBI]
|
7.7398e-06
|
|
|
PEX12
|
[NCBI]
|
7.7398e-06
|
|
|
DIO1
|
[NCBI]
|
7.7398e-06
|
|
|
CR2
|
[NCBI]
|
7.7398e-06
|
|
|
SLC17A8
|
[NCBI]
|
7.7398e-06
|
|
|
PTGER3
|
[NCBI]
|
7.7398e-06
|
|
|
AIP
|
[NCBI]
|
7.7398e-06
|
|
|
DSG4
|
[NCBI]
|
7.7398e-06
|
|
|
TNNI2
|
[NCBI]
|
7.7398e-06
|
|
|
GCNT2
|
[NCBI]
|
7.7398e-06
|
|
|
SYT2
|
[NCBI]
|
7.7398e-06
|
|
|
CD3E
|
[NCBI]
|
7.7398e-06
|
|
|
APBA1
|
[NCBI]
|
7.7398e-06
|
|
|
RPS4X
|
[NCBI]
|
7.7398e-06
|
|
|
PTGER2
|
[NCBI]
|
7.7398e-06
|
|
|
ZIC2
|
[NCBI]
|
7.7398e-06
|
|
|
ALMS1
|
[NCBI]
|
7.7398e-06
|
|
|
ANKH
|
[NCBI]
|
7.7398e-06
|
|
|
FSHMD1A
|
[NCBI]
|
7.70336e-06
|
|
|
alopecia, androgenetic
|
[NCBI]
|
7.68891e-06
|
|
|
CDA
|
[NCBI]
|
7.65234e-06
|
|
|
myoclonic dystonia
|
[NCBI]
|
7.63916e-06
|
|
|
TYMS
|
[NCBI]
|
7.49396e-06
|
|
|
INSR
|
[NCBI]
|
7.48901e-06
|
|
|
MFS
|
[NCBI]
|
7.46047e-06
|
|
|
ABCA4
|
[NCBI]
|
7.44248e-06
|
|
|
MTCYB
|
[NCBI]
|
7.23906e-06
|
|
|
NXF1
|
[NCBI]
|
7.21406e-06
|
|
|
TREM2
|
[NCBI]
|
7.21406e-06
|
|
|
NPHP1
|
[NCBI]
|
7.21406e-06
|
|
|
FACL4
|
[NCBI]
|
7.21406e-06
|
|
|
TAGLN
|
[NCBI]
|
7.21406e-06
|
|
|
INSIG2
|
[NCBI]
|
7.21406e-06
|
|
|
NPPB
|
[NCBI]
|
7.21406e-06
|
|
|
SGCG
|
[NCBI]
|
7.21406e-06
|
|
|
HESX1
|
[NCBI]
|
7.21406e-06
|
|
|
LIM2
|
[NCBI]
|
7.21406e-06
|
|
|
STXBP1
|
[NCBI]
|
7.21406e-06
|
|
|
PLEC1
|
[NCBI]
|
7.21406e-06
|
|
|
HTR1A
|
[NCBI]
|
7.21406e-06
|
|
|
KERA
|
[NCBI]
|
7.21406e-06
|
|
|
COL5A2
|
[NCBI]
|
7.21406e-06
|
|
|
TEF
|
[NCBI]
|
7.21406e-06
|
|
|
TAS1R3
|
[NCBI]
|
7.21406e-06
|
|
|
PRND
|
[NCBI]
|
7.21406e-06
|
|
|
BIN1
|
[NCBI]
|
7.21406e-06
|
|
|
NR2E3
|
[NCBI]
|
7.21406e-06
|
|
|
GATA2
|
[NCBI]
|
7.21406e-06
|
|
|
HTR1B
|
[NCBI]
|
7.21406e-06
|
|
|
RORA
|
[NCBI]
|
7.21406e-06
|
|
|
POMGNT1
|
[NCBI]
|
7.21406e-06
|
|
|
CDPX2
|
[NCBI]
|
7.05279e-06
|
|
|
CADASIL
|
[NCBI]
|
7.05279e-06
|
|
|
USF1
|
[NCBI]
|
7.04179e-06
|
|
|
FMF
|
[NCBI]
|
7.03128e-06
|
|
|
HLA-A
|
[NCBI]
|
6.94395e-06
|
|
|
alzheimer disease 2
|
[NCBI]
|
6.94184e-06
|
|
|
chromosome 18q deletion syndrome
|
[NCBI]
|
6.94184e-06
|
|
|
acyl-coa dehydrogenase, short-chain, deficiency of
|
[NCBI]
|
6.94184e-06
|
|
|
chromosome 22q13.3 deletion syndrome
|
[NCBI]
|
6.94184e-06
|
|
|
indifference to pain, congenital, autosomal recessive
|
[NCBI]
|
6.94184e-06
|
|
|
EDM1
|
[NCBI]
|
6.94184e-06
|
|
|
pick disease of brain
|
[NCBI]
|
6.94184e-06
|
|
|
BMND1
|
[NCBI]
|
6.94184e-06
|
|
|
XPD
|
[NCBI]
|
6.94184e-06
|
|
|
OPD1
|
[NCBI]
|
6.94184e-06
|
|
|
RENS1
|
[NCBI]
|
6.94184e-06
|
|
|
GRTH
|
[NCBI]
|
6.94184e-06
|
|
|
epidermolysis bullosa simplex and limb-girdle muscular dystrophy
|
[NCBI]
|
6.94184e-06
|
|
|
WS2A
|
[NCBI]
|
6.94184e-06
|
|
|
septooptic dysplasia
|
[NCBI]
|
6.94184e-06
|
|
|
AEZ
|
[NCBI]
|
6.94184e-06
|
|
|
temporal arteritis
|
[NCBI]
|
6.9201e-06
|
|
|
GSR
|
[NCBI]
|
6.8504e-06
|
|
|
TCRA
|
[NCBI]
|
6.8504e-06
|
|
|
TNFRSF1A
|
[NCBI]
|
6.81796e-06
|
|
|
CRHR2
|
[NCBI]
|
6.74265e-06
|
|
|
SUZ12
|
[NCBI]
|
6.74265e-06
|
|
|
MLC1
|
[NCBI]
|
6.74265e-06
|
|
|
SAG
|
[NCBI]
|
6.74265e-06
|
|
|
CKM
|
[NCBI]
|
6.74265e-06
|
|
|
GABBR2
|
[NCBI]
|
6.74265e-06
|
|
|
TFAP2B
|
[NCBI]
|
6.74265e-06
|
|
|
HPS1
|
[NCBI]
|
6.74265e-06
|
|
|
AMBP
|
[NCBI]
|
6.74265e-06
|
|
|
CDKN2B
|
[NCBI]
|
6.74265e-06
|
|
|
SOAT1
|
[NCBI]
|
6.74265e-06
|
|
|
PAX9
|
[NCBI]
|
6.74265e-06
|
|
|
IL12RB1
|
[NCBI]
|
6.74265e-06
|
|
|
SPTLC1
|
[NCBI]
|
6.74265e-06
|
|
|
CXORF5
|
[NCBI]
|
6.74265e-06
|
|
|
EIF2AK3
|
[NCBI]
|
6.74265e-06
|
|
|
loc387715 gene
|
[NCBI]
|
6.74265e-06
|
|
|
ORM2
|
[NCBI]
|
6.74265e-06
|
|
|
MATN1
|
[NCBI]
|
6.74265e-06
|
|
|
FUT3
|
[NCBI]
|
6.74265e-06
|
|
|
KIR2DL1
|
[NCBI]
|
6.74265e-06
|
|
|
ERAF
|
[NCBI]
|
6.74265e-06
|
|
|
MYF5
|
[NCBI]
|
6.74265e-06
|
|
|
FUR
|
[NCBI]
|
6.74265e-06
|
|
|
TRIM24
|
[NCBI]
|
6.74265e-06
|
|
|
SLC7A9
|
[NCBI]
|
6.74265e-06
|
|
|
MS4A2
|
[NCBI]
|
6.74265e-06
|
|
|
MEIS1
|
[NCBI]
|
6.74265e-06
|
|
|
TIMELESS
|
[NCBI]
|
6.74265e-06
|
|
|
PON2
|
[NCBI]
|
6.74265e-06
|
|
|
COL2A1
|
[NCBI]
|
6.6941e-06
|
|
|
TP53
|
[NCBI]
|
6.67811e-06
|
|
|
ETL2
|
[NCBI]
|
6.55149e-06
|
|
|
restless legs syndrome, susceptibility to, 1
|
[NCBI]
|
6.50873e-06
|
|
|
L1CAM
|
[NCBI]
|
6.48427e-06
|
|
|
DCT
|
[NCBI]
|
6.48427e-06
|
|
|
GCK
|
[NCBI]
|
6.45261e-06
|
|
|
glycogen storage disease ii
|
[NCBI]
|
6.41618e-06
|
|
|
ADM
|
[NCBI]
|
6.38468e-06
|
|
|
FGF1
|
[NCBI]
|
6.33488e-06
|
|
|
ASCL1
|
[NCBI]
|
6.31648e-06
|
|
|
SIX1
|
[NCBI]
|
6.31648e-06
|
|
|
MOG
|
[NCBI]
|
6.31648e-06
|
|
|
SPINK5
|
[NCBI]
|
6.31648e-06
|
|
|
PRKAG2
|
[NCBI]
|
6.31648e-06
|
|
|
LTA4H
|
[NCBI]
|
6.31648e-06
|
|
|
RIMS1
|
[NCBI]
|
6.31648e-06
|
|
|
CCL27
|
[NCBI]
|
6.31648e-06
|
|
|
SELL
|
[NCBI]
|
6.31648e-06
|
|
|
ATP2A1
|
[NCBI]
|
6.31648e-06
|
|
|
FCGR2B
|
[NCBI]
|
6.31648e-06
|
|
|
TFE3
|
[NCBI]
|
6.31648e-06
|
|
|
NRF1
|
[NCBI]
|
6.31648e-06
|
|
|
SEPT9
|
[NCBI]
|
6.31648e-06
|
|
|
OLIG2
|
[NCBI]
|
6.31648e-06
|
|
|
OCRL
|
[NCBI]
|
6.31648e-06
|
|
|
CTNNA1
|
[NCBI]
|
6.31648e-06
|
|
|
PPP1R1B
|
[NCBI]
|
6.31648e-06
|
|
|
SOX3
|
[NCBI]
|
6.31648e-06
|
|
|
COL7A1
|
[NCBI]
|
6.30907e-06
|
|
|
MSTN
|
[NCBI]
|
6.13882e-06
|
|
|
porphyria variegata
|
[NCBI]
|
6.10877e-06
|
|
|
MODY1
|
[NCBI]
|
6.00946e-06
|
|
|
ISS
|
[NCBI]
|
6.00946e-06
|
|
|
anemia, dyserythropoietic congenital, type i
|
[NCBI]
|
6.00946e-06
|
|
|
CFEOM1
|
[NCBI]
|
6.00946e-06
|
|
|
LQT3
|
[NCBI]
|
6.00946e-06
|
|
|
JME
|
[NCBI]
|
6.00946e-06
|
|
|
AGS1
|
[NCBI]
|
6.00946e-06
|
|
|
JLNS1
|
[NCBI]
|
6.00946e-06
|
|
|
PNDM
|
[NCBI]
|
6.00946e-06
|
|
|
diabetes insipidus, nephrogenic, autosomal
|
[NCBI]
|
6.00946e-06
|
|
|
PPS
|
[NCBI]
|
6.00946e-06
|
|
|
tetralogy of fallot
|
[NCBI]
|
6.00946e-06
|
|
|
ACHM2
|
[NCBI]
|
6.00946e-06
|
|
|
OPD2
|
[NCBI]
|
6.00946e-06
|
|
|
HSCR2
|
[NCBI]
|
6.00946e-06
|
|
|
LEPR
|
[NCBI]
|
5.99328e-06
|
|
|
OCA1A
|
[NCBI]
|
5.98222e-06
|
|
|
nijmegen breakage syndrome
|
[NCBI]
|
5.98222e-06
|
|
|
XRCC2
|
[NCBI]
|
5.92857e-06
|
|
|
MPI
|
[NCBI]
|
5.92857e-06
|
|
|
SFTPC
|
[NCBI]
|
5.92857e-06
|
|
|
PIM1
|
[NCBI]
|
5.92857e-06
|
|
|
IKBKAP
|
[NCBI]
|
5.92857e-06
|
|
|
ADH1
|
[NCBI]
|
5.92857e-06
|
|
|
TPM1
|
[NCBI]
|
5.92857e-06
|
|
|
CPT1A
|
[NCBI]
|
5.92857e-06
|
|
|
TRAPPC2
|
[NCBI]
|
5.92857e-06
|
|
|
EIF2B5
|
[NCBI]
|
5.92857e-06
|
|
|
CEP290
|
[NCBI]
|
5.92857e-06
|
|
|
GOT1
|
[NCBI]
|
5.92857e-06
|
|
|
CCS
|
[NCBI]
|
5.92857e-06
|
|
|
TCF4
|
[NCBI]
|
5.92857e-06
|
|
|
HLCS
|
[NCBI]
|
5.92857e-06
|
|
|
EN2
|
[NCBI]
|
5.92857e-06
|
|
|
DRD1
|
[NCBI]
|
5.92857e-06
|
|
|
KRT9
|
[NCBI]
|
5.92857e-06
|
|
|
tyrosine transaminase deficiency
|
[NCBI]
|
5.92857e-06
|
|
|
PDE4D
|
[NCBI]
|
5.92857e-06
|
|
|
CDK5
|
[NCBI]
|
5.85416e-06
|
|
|
SH2D1A
|
[NCBI]
|
5.81244e-06
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
5.80654e-06
|
|
|
PTGS2
|
[NCBI]
|
5.77482e-06
|
|
|
GHR
|
[NCBI]
|
5.67647e-06
|
|
|
F13A1
|
[NCBI]
|
5.65594e-06
|
|
|
CFB
|
[NCBI]
|
5.65594e-06
|
|
|
SCN5A
|
[NCBI]
|
5.65594e-06
|
|
|
DRPLA
|
[NCBI]
|
5.65239e-06
|
|
|
SF1
|
[NCBI]
|
5.57344e-06
|
|
|
TBXA2R
|
[NCBI]
|
5.57344e-06
|
|
|
EFNB1
|
[NCBI]
|
5.57344e-06
|
|
|
GALR1
|
[NCBI]
|
5.57344e-06
|
|
|
ADAR
|
[NCBI]
|
5.57344e-06
|
|
|
AGXT
|
[NCBI]
|
5.57344e-06
|
|
|
MTMR2
|
[NCBI]
|
5.57344e-06
|
|
|
TNNI3
|
[NCBI]
|
5.57344e-06
|
|
|
JUP
|
[NCBI]
|
5.57344e-06
|
|
|
PLA2G7
|
[NCBI]
|
5.57344e-06
|
|
|
NOTCH3
|
[NCBI]
|
5.57344e-06
|
|
|
SORBS1
|
[NCBI]
|
5.57344e-06
|
|
|
SMARCB1
|
[NCBI]
|
5.57344e-06
|
|
|
NEFH
|
[NCBI]
|
5.57344e-06
|
|
|
CACNA1F
|
[NCBI]
|
5.57344e-06
|
|
|
HSPG2
|
[NCBI]
|
5.57344e-06
|
|
|
CD1D
|
[NCBI]
|
5.57344e-06
|
|
|
ND
|
[NCBI]
|
5.50889e-06
|
|
|
TG
|
[NCBI]
|
5.4971e-06
|
|
|
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity
|
[NCBI]
|
5.49427e-06
|
|
|
PDS
|
[NCBI]
|
5.49427e-06
|
|
|
MAG
|
[NCBI]
|
5.33653e-06
|
|
|
APOE
|
[NCBI]
|
5.27181e-06
|
|
|
GNAS
|
[NCBI]
|
5.25901e-06
|
|
|
DRD5
|
[NCBI]
|
5.24671e-06
|
|
|
SOCS2
|
[NCBI]
|
5.24671e-06
|
|
|
HPSE
|
[NCBI]
|
5.24671e-06
|
|
|
PDC
|
[NCBI]
|
5.24671e-06
|
|
|
ECE1
|
[NCBI]
|
5.24671e-06
|
|
|
EPAS1
|
[NCBI]
|
5.24671e-06
|
|
|
PLAU
|
[NCBI]
|
5.24671e-06
|
|
|
SLC26A3
|
[NCBI]
|
5.24671e-06
|
|
|
SDHB
|
[NCBI]
|
5.24671e-06
|
|
|
POMT1
|
[NCBI]
|
5.24671e-06
|
|
|
OTOF
|
[NCBI]
|
5.24671e-06
|
|
|
IGLC1
|
[NCBI]
|
5.24671e-06
|
|
|
MTND4L
|
[NCBI]
|
5.24671e-06
|
|
|
APOA4
|
[NCBI]
|
5.24671e-06
|
|
|
TULP1
|
[NCBI]
|
5.24671e-06
|
|
|
FOXP2
|
[NCBI]
|
5.24671e-06
|
|
|
vitamin d-dependent rickets, type i
|
[NCBI]
|
5.18747e-06
|
|
|
dent disease 1
|
[NCBI]
|
5.18747e-06
|
|
|
MCPH1
|
[NCBI]
|
5.18747e-06
|
|
|
mowat-wilson syndrome
|
[NCBI]
|
5.18747e-06
|
|
|
ADLTE
|
[NCBI]
|
5.18747e-06
|
|
|
CTHM
|
[NCBI]
|
5.18747e-06
|
|
|
PALS
|
[NCBI]
|
5.18747e-06
|
|
|
potocki-shaffer syndrome
|
[NCBI]
|
5.18747e-06
|
|
|
holocarboxylase synthetase deficiency
|
[NCBI]
|
5.18747e-06
|
|
|
omenn syndrome
|
[NCBI]
|
5.18747e-06
|
|
|
CHNG1
|
[NCBI]
|
5.18747e-06
|
|
|
HMS1
|
[NCBI]
|
5.18747e-06
|
|
|
PLP1
|
[NCBI]
|
5.07081e-06
|
|
|
NFKBIA
|
[NCBI]
|
4.94483e-06
|
|
|
PANK2
|
[NCBI]
|
4.94483e-06
|
|
|
PRKCA
|
[NCBI]
|
4.94483e-06
|
|
|
SGCA
|
[NCBI]
|
4.94483e-06
|
|
|
SLC26A2
|
[NCBI]
|
4.94483e-06
|
|
|
LAMP2
|
[NCBI]
|
4.94483e-06
|
|
|
SELE
|
[NCBI]
|
4.94483e-06
|
|
|
ANGPT1
|
[NCBI]
|
4.94483e-06
|
|
|
SCARB1
|
[NCBI]
|
4.94483e-06
|
|
|
ALOX5
|
[NCBI]
|
4.94483e-06
|
|
|
TERF1
|
[NCBI]
|
4.94483e-06
|
|
|
ADRB1
|
[NCBI]
|
4.94483e-06
|
|
|
TXNIP
|
[NCBI]
|
4.94483e-06
|
|
|
THBD
|
[NCBI]
|
4.94483e-06
|
|
|
ATXN3
|
[NCBI]
|
4.94483e-06
|
|
|
LYST
|
[NCBI]
|
4.94483e-06
|
|
|
MTTS1
|
[NCBI]
|
4.94483e-06
|
|
|
KEAP1
|
[NCBI]
|
4.94483e-06
|
|
|
DRD2
|
[NCBI]
|
4.93403e-06
|
|
|
REN
|
[NCBI]
|
4.93403e-06
|
|
|
DCC
|
[NCBI]
|
4.93403e-06
|
|
|
gaucher disease, type i
|
[NCBI]
|
4.92867e-06
|
|
|
OFC1
|
[NCBI]
|
4.90205e-06
|
|
|
FFI
|
[NCBI]
|
4.79044e-06
|
|
|
RB1
|
[NCBI]
|
4.7338e-06
|
|
|
PSEN1
|
[NCBI]
|
4.70512e-06
|
|
|
TBX1
|
[NCBI]
|
4.66485e-06
|
|
|
CAST
|
[NCBI]
|
4.66485e-06
|
|
|
DLL3
|
[NCBI]
|
4.66485e-06
|
|
|
TAZ
|
[NCBI]
|
4.66485e-06
|
|
|
SLC22A8
|
[NCBI]
|
4.66485e-06
|
|
|
PAX1
|
[NCBI]
|
4.66485e-06
|
|
|
KCNQ1OT1
|
[NCBI]
|
4.66485e-06
|
|
|
CCR2
|
[NCBI]
|
4.66485e-06
|
|
|
MYO6
|
[NCBI]
|
4.66485e-06
|
|
|
CBFA2T1
|
[NCBI]
|
4.66485e-06
|
|
|
USH2A
|
[NCBI]
|
4.66485e-06
|
|
|
ROR2
|
[NCBI]
|
4.66485e-06
|
|
|
CYP11A1
|
[NCBI]
|
4.66485e-06
|
|
|
FGB
|
[NCBI]
|
4.66485e-06
|
|
|
SMEI
|
[NCBI]
|
4.60479e-06
|
|
|
CDH1
|
[NCBI]
|
4.54445e-06
|
|
|
IGF1
|
[NCBI]
|
4.54445e-06
|
|
|
MMP9
|
[NCBI]
|
4.54445e-06
|
|
|
robinow syndrome, autosomal recessive
|
[NCBI]
|
4.46112e-06
|
|
|
severe combined immunodeficiency with sensitivity to ionizing radiation
|
[NCBI]
|
4.46112e-06
|
|
|
CMDD
|
[NCBI]
|
4.46112e-06
|
|
|
GCE
|
[NCBI]
|
4.46112e-06
|
|
|
seckel syndrome 1
|
[NCBI]
|
4.46112e-06
|
|
|
VED
|
[NCBI]
|
4.46112e-06
|
|
|
coumarin resistance
|
[NCBI]
|
4.46112e-06
|
|
|
PPAC
|
[NCBI]
|
4.46112e-06
|
|
|
IPEX
|
[NCBI]
|
4.46112e-06
|
|
|
pyruvate carboxylase deficiency
|
[NCBI]
|
4.46112e-06
|
|
|
hurler-scheie syndrome
|
[NCBI]
|
4.46112e-06
|
|
|
UCHL1
|
[NCBI]
|
4.40435e-06
|
|
|
G6PC2
|
[NCBI]
|
4.40435e-06
|
|
|
IL6R
|
[NCBI]
|
4.40435e-06
|
|
|
GDI1
|
[NCBI]
|
4.40435e-06
|
|
|
TRHR
|
[NCBI]
|
4.40435e-06
|
|
|
NEFL
|
[NCBI]
|
4.40435e-06
|
|
|
C5
|
[NCBI]
|
4.40435e-06
|
|
|
FOXC1
|
[NCBI]
|
4.40435e-06
|
|
|
VCAM1
|
[NCBI]
|
4.40435e-06
|
|
|
GLRA1
|
[NCBI]
|
4.40435e-06
|
|
|
SPG7
|
[NCBI]
|
4.40435e-06
|
|
|
GLDC
|
[NCBI]
|
4.40435e-06
|
|
|
USH1C
|
[NCBI]
|
4.40435e-06
|
|
|
MBP
|
[NCBI]
|
4.3683e-06
|
|
|
behcet syndrome
|
[NCBI]
|
4.34773e-06
|
|
|
BCNS
|
[NCBI]
|
4.33244e-06
|
|
|
ITGB3
|
[NCBI]
|
4.30091e-06
|
|
|
SPTA1
|
[NCBI]
|
4.18369e-06
|
|
|
NR4A2
|
[NCBI]
|
4.16128e-06
|
|
|
PQBP1
|
[NCBI]
|
4.16128e-06
|
|
|
LMX1B
|
[NCBI]
|
4.16128e-06
|
|
|
COL11A2
|
[NCBI]
|
4.16128e-06
|
|
|
FGF3
|
[NCBI]
|
4.16128e-06
|
|
|
FOXL2
|
[NCBI]
|
4.16128e-06
|
|
|
ADRB3
|
[NCBI]
|
4.16128e-06
|
|
|
TERF2
|
[NCBI]
|
4.16128e-06
|
|
|
KCNE1
|
[NCBI]
|
4.16128e-06
|
|
|
PPARG
|
[NCBI]
|
4.09712e-06
|
|
|
UGT1A1
|
[NCBI]
|
4.06938e-06
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
4.05811e-06
|
|
|
TF
|
[NCBI]
|
3.94963e-06
|
|
|
CHRNA4
|
[NCBI]
|
3.93387e-06
|
|
|
GALK1
|
[NCBI]
|
3.93387e-06
|
|
|
PHOX2B
|
[NCBI]
|
3.93387e-06
|
|
|
PPARD
|
[NCBI]
|
3.93387e-06
|
|
|
AMY1A
|
[NCBI]
|
3.93387e-06
|
|
|
EPB41
|
[NCBI]
|
3.93387e-06
|
|
|
NNMT
|
[NCBI]
|
3.93387e-06
|
|
|
DBT
|
[NCBI]
|
3.93387e-06
|
|
|
HSD11B1
|
[NCBI]
|
3.93387e-06
|
|
|
SYT1
|
[NCBI]
|
3.93387e-06
|
|
|
WNK1
|
[NCBI]
|
3.93387e-06
|
|
|
DHCR7
|
[NCBI]
|
3.93387e-06
|
|
|
AMELX
|
[NCBI]
|
3.93387e-06
|
|
|
VHL
|
[NCBI]
|
3.90235e-06
|
|
|
TGFB1
|
[NCBI]
|
3.84912e-06
|
|
|
CD36
|
[NCBI]
|
3.84912e-06
|
|
|
HSAN3
|
[NCBI]
|
3.82093e-06
|
|
|
MKKS
|
[NCBI]
|
3.81843e-06
|
|
|
refsum disease
|
[NCBI]
|
3.81843e-06
|
|
|
longevity
|
[NCBI]
|
3.81843e-06
|
|
|
thyroid hormonogenesis, genetic defect in, 2a
|
[NCBI]
|
3.81843e-06
|
|
|
SPCH1
|
[NCBI]
|
3.81843e-06
|
|
|
SCZD1
|
[NCBI]
|
3.81843e-06
|
|
|
TMAU
|
[NCBI]
|
3.81843e-06
|
|
|
PHA
|
[NCBI]
|
3.81843e-06
|
|
|
OPTB3
|
[NCBI]
|
3.81843e-06
|
|
|
periodontitis, aggressive, 1
|
[NCBI]
|
3.81843e-06
|
|
|
neural tube defects, folate-sensitive
|
[NCBI]
|
3.81843e-06
|
|
|
SPG2
|
[NCBI]
|
3.81843e-06
|
|
|
NRL
|
[NCBI]
|
3.72066e-06
|
|
|
CHRNA1
|
[NCBI]
|
3.72066e-06
|
|
|
CTSD
|
[NCBI]
|
3.72066e-06
|
|
|
CR1
|
[NCBI]
|
3.72066e-06
|
|
|
ITGB1
|
[NCBI]
|
3.72066e-06
|
|
|
PEX7
|
[NCBI]
|
3.72066e-06
|
|
|
CLCN5
|
[NCBI]
|
3.72066e-06
|
|
|
GPR54
|
[NCBI]
|
3.72066e-06
|
|
|
HLA-G
|
[NCBI]
|
3.72066e-06
|
|
|
LCAT
|
[NCBI]
|
3.62244e-06
|
|
|
IL1RN
|
[NCBI]
|
3.52033e-06
|
|
|
MYB
|
[NCBI]
|
3.52033e-06
|
|
|
DKC1
|
[NCBI]
|
3.52033e-06
|
|
|
ATP2A2
|
[NCBI]
|
3.52033e-06
|
|
|
KRT1
|
[NCBI]
|
3.52033e-06
|
|
|
PAX5
|
[NCBI]
|
3.52033e-06
|
|
|
PDGFRA
|
[NCBI]
|
3.52033e-06
|
|
|
PLOD1
|
[NCBI]
|
3.52033e-06
|
|
|
GHRHR
|
[NCBI]
|
3.52033e-06
|
|
|
SELP
|
[NCBI]
|
3.52033e-06
|
|
|
SYP
|
[NCBI]
|
3.52033e-06
|
|
|
F12
|
[NCBI]
|
3.52033e-06
|
|
|
CYP27B1
|
[NCBI]
|
3.52033e-06
|
|
|
OR1D2
|
[NCBI]
|
3.52033e-06
|
|
|
EBP
|
[NCBI]
|
3.52033e-06
|
|
|
COMP
|
[NCBI]
|
3.5031e-06
|
|
|
VMD
|
[NCBI]
|
3.4654e-06
|
|
|
FAAH
|
[NCBI]
|
3.46091e-06
|
|
|
SLC6A3
|
[NCBI]
|
3.36963e-06
|
|
|
MITF
|
[NCBI]
|
3.3528e-06
|
|
|
ADHD
|
[NCBI]
|
3.33341e-06
|
|
|
PAX8
|
[NCBI]
|
3.33177e-06
|
|
|
CTSB
|
[NCBI]
|
3.33177e-06
|
|
|
ANXA5
|
[NCBI]
|
3.33177e-06
|
|
|
LTC4S
|
[NCBI]
|
3.33177e-06
|
|
|
VAMP2
|
[NCBI]
|
3.33177e-06
|
|
|
AACT
|
[NCBI]
|
3.33177e-06
|
|
|
HSPA1A
|
[NCBI]
|
3.33177e-06
|
|
|
GATA3
|
[NCBI]
|
3.33177e-06
|
|
|
NR3C2
|
[NCBI]
|
3.33177e-06
|
|
|
APTX
|
[NCBI]
|
3.33177e-06
|
|
|
giant platelet syndrome
|
[NCBI]
|
3.30325e-06
|
|
|
DCK
|
[NCBI]
|
3.25201e-06
|
|
|
TSC2
|
[NCBI]
|
3.24962e-06
|
|
|
MC4R
|
[NCBI]
|
3.24962e-06
|
|
|
MNS
|
[NCBI]
|
3.24955e-06
|
|
|
glucose transport defect, blood-brain barrier
|
[NCBI]
|
3.24955e-06
|
|
|
properdin deficiency, x-linked
|
[NCBI]
|
3.24955e-06
|
|
|
EAOH
|
[NCBI]
|
3.24955e-06
|
|
|
IBGC1
|
[NCBI]
|
3.24841e-06
|
|
|
CBBM
|
[NCBI]
|
3.24841e-06
|
|
|
VCP
|
[NCBI]
|
3.15791e-06
|
|
|
HNF1B
|
[NCBI]
|
3.154e-06
|
|
|
IRF1
|
[NCBI]
|
3.154e-06
|
|
|
DRPLA
|
[NCBI]
|
3.154e-06
|
|
|
PINK1
|
[NCBI]
|
3.154e-06
|
|
|
MFN2
|
[NCBI]
|
3.154e-06
|
|
|
EDA
|
[NCBI]
|
3.154e-06
|
|
|
ABL
|
[NCBI]
|
3.13262e-06
|
|
|
lynch syndrome i
|
[NCBI]
|
3.01465e-06
|
|
|
MIP
|
[NCBI]
|
2.98616e-06
|
|
|
RPS19
|
[NCBI]
|
2.98616e-06
|
|
|
EGR2
|
[NCBI]
|
2.98616e-06
|
|
|
GSK3B
|
[NCBI]
|
2.98616e-06
|
|
|
NKX2E
|
[NCBI]
|
2.98616e-06
|
|
|
SLC12A3
|
[NCBI]
|
2.98616e-06
|
|
|
SST
|
[NCBI]
|
2.96545e-06
|
|
|
PEDF
|
[NCBI]
|
2.9251e-06
|
|
|
TTR
|
[NCBI]
|
2.9067e-06
|
|
|
CHM
|
[NCBI]
|
2.83546e-06
|
|
|
hurler syndrome
|
[NCBI]
|
2.83546e-06
|
|
|
IL2RG
|
[NCBI]
|
2.82748e-06
|
|
|
RBP3
|
[NCBI]
|
2.82748e-06
|
|
|
SCIDX1
|
[NCBI]
|
2.82153e-06
|
|
|
SCS
|
[NCBI]
|
2.82153e-06
|
|
|
PMP22
|
[NCBI]
|
2.80112e-06
|
|
|
INS
|
[NCBI]
|
2.79357e-06
|
|
|
TLR4
|
[NCBI]
|
2.78798e-06
|
|
|
HNA
|
[NCBI]
|
2.74625e-06
|
|
|
VWM
|
[NCBI]
|
2.74625e-06
|
|
|
EBN1
|
[NCBI]
|
2.74625e-06
|
|
|
AIED
|
[NCBI]
|
2.74625e-06
|
|
|
ESCS
|
[NCBI]
|
2.74625e-06
|
|
|
TSG101
|
[NCBI]
|
2.67727e-06
|
|
|
PPARGC1A
|
[NCBI]
|
2.67727e-06
|
|
|
PTPN1
|
[NCBI]
|
2.67727e-06
|
|
|
AHSG
|
[NCBI]
|
2.67727e-06
|
|
|
CRYAB
|
[NCBI]
|
2.67727e-06
|
|
|
CD4
|
[NCBI]
|
2.67727e-06
|
|
|
EYA1
|
[NCBI]
|
2.67727e-06
|
|
|
RCC1
|
[NCBI]
|
2.60288e-06
|
|
|
WHS
|
[NCBI]
|
2.56591e-06
|
|
|
SLC17A7
|
[NCBI]
|
2.53494e-06
|
|
|
CES1
|
[NCBI]
|
2.53494e-06
|
|
|
PRKAR1A
|
[NCBI]
|
2.53494e-06
|
|
|
INPP5D
|
[NCBI]
|
2.53494e-06
|
|
|
TNNT2
|
[NCBI]
|
2.53494e-06
|
|
|
PTCH1
|
[NCBI]
|
2.53494e-06
|
|
|
MUT
|
[NCBI]
|
2.53494e-06
|
|
|
ITGA2B
|
[NCBI]
|
2.53494e-06
|
|
|
PGR
|
[NCBI]
|
2.5047e-06
|
|
|
factor v deficiency
|
[NCBI]
|
2.42382e-06
|
|
|
IPF1
|
[NCBI]
|
2.39995e-06
|
|
|
FABP2
|
[NCBI]
|
2.39995e-06
|
|
|
HLA-DQA1
|
[NCBI]
|
2.39995e-06
|
|
|
SLC25A4
|
[NCBI]
|
2.39995e-06
|
|
|
APEX
|
[NCBI]
|
2.39995e-06
|
|
|
SLC3A2
|
[NCBI]
|
2.39995e-06
|
|
|
TNFRSF10A
|
[NCBI]
|
2.39995e-06
|
|
|
NOG
|
[NCBI]
|
2.39995e-06
|
|
|
IGF2R
|
[NCBI]
|
2.39995e-06
|
|
|
KRT14
|
[NCBI]
|
2.39995e-06
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
2.35579e-06
|
|
|
mucopolysaccharidosis type iiib
|
[NCBI]
|
2.30163e-06
|
|
|
DA2A
|
[NCBI]
|
2.30163e-06
|
|
|
epidermolysis bullosa letalis
|
[NCBI]
|
2.30163e-06
|
|
|
autonomic control, congenital failure of
|
[NCBI]
|
2.30163e-06
|
|
|
EL1
|
[NCBI]
|
2.30163e-06
|
|
|
TTN
|
[NCBI]
|
2.2718e-06
|
|
|
CHGA
|
[NCBI]
|
2.2718e-06
|
|
|
RYR2
|
[NCBI]
|
2.2718e-06
|
|
|
HSPB1
|
[NCBI]
|
2.2718e-06
|
|
|
PTX3
|
[NCBI]
|
2.2718e-06
|
|
|
CMT1B
|
[NCBI]
|
2.26061e-06
|
|
|
ASS
|
[NCBI]
|
2.21187e-06
|
|
|
IGAN1
|
[NCBI]
|
2.16888e-06
|
|
|
proteus syndrome
|
[NCBI]
|
2.16888e-06
|
|
|
CDAN2
|
[NCBI]
|
2.16888e-06
|
|
|
ADH5
|
[NCBI]
|
2.15004e-06
|
|
|
ACVRL1
|
[NCBI]
|
2.15004e-06
|
|
|
IL1B
|
[NCBI]
|
2.15004e-06
|
|
|
TGFBR2
|
[NCBI]
|
2.15004e-06
|
|
|
STAT4
|
[NCBI]
|
2.15004e-06
|
|
|
RBP4
|
[NCBI]
|
2.15004e-06
|
|
|
ATXN1
|
[NCBI]
|
2.15004e-06
|
|
|
CYP11B2
|
[NCBI]
|
2.15004e-06
|
|
|
IRS2
|
[NCBI]
|
2.15004e-06
|
|
|
GCDH
|
[NCBI]
|
2.15004e-06
|
|
|
CST3
|
[NCBI]
|
2.15004e-06
|
|
|
ABCG2
|
[NCBI]
|
2.11526e-06
|
|
|
G6PD
|
[NCBI]
|
2.09222e-06
|
|
|
FTL
|
[NCBI]
|
2.03429e-06
|
|
|
PTPN11
|
[NCBI]
|
2.03429e-06
|
|
|
GLI3
|
[NCBI]
|
2.03429e-06
|
|
|
COL6A1
|
[NCBI]
|
2.03429e-06
|
|
|
DCN
|
[NCBI]
|
2.03429e-06
|
|
|
GCH1
|
[NCBI]
|
2.03429e-06
|
|
|
UCP3
|
[NCBI]
|
2.01442e-06
|
|
|
BRRS
|
[NCBI]
|
2.00902e-06
|
|
|
PD
|
[NCBI]
|
1.9587e-06
|
|
|
AMC
|
[NCBI]
|
1.94998e-06
|
|
|
maple syrup urine disease
|
[NCBI]
|
1.94998e-06
|
|
|
AN2
|
[NCBI]
|
1.94998e-06
|
|
|
TERC
|
[NCBI]
|
1.92418e-06
|
|
|
MN
|
[NCBI]
|
1.92418e-06
|
|
|
RECQL3
|
[NCBI]
|
1.92418e-06
|
|
|
CGL2
|
[NCBI]
|
1.90981e-06
|
|
|
EDMD2
|
[NCBI]
|
1.90981e-06
|
|
|
CCAL2
|
[NCBI]
|
1.90981e-06
|
|
|
RIEG1
|
[NCBI]
|
1.90981e-06
|
|
|
EBR1
|
[NCBI]
|
1.90981e-06
|
|
|
hyperoxaluria, primary, type i
|
[NCBI]
|
1.90981e-06
|
|
|
HSAN1
|
[NCBI]
|
1.90981e-06
|
|
|
FMR1
|
[NCBI]
|
1.89864e-06
|
|
|
COL1A2
|
[NCBI]
|
1.8305e-06
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
1.8305e-06
|
|
|
HEXA
|
[NCBI]
|
1.8305e-06
|
|
|
SOX10
|
[NCBI]
|
1.81937e-06
|
|
|
DNMT3B
|
[NCBI]
|
1.81937e-06
|
|
|
ADORA3
|
[NCBI]
|
1.81937e-06
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
1.76615e-06
|
|
|
NF2
|
[NCBI]
|
1.7483e-06
|
|
|
obesity
|
[NCBI]
|
1.7483e-06
|
|
|
GRA
|
[NCBI]
|
1.7483e-06
|
|
|
GLB1
|
[NCBI]
|
1.71956e-06
|
|
|
SPG4
|
[NCBI]
|
1.71956e-06
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
1.71956e-06
|
|
|
HNF1A
|
[NCBI]
|
1.71498e-06
|
|
|
SOD1
|
[NCBI]
|
1.70522e-06
|
|
|
PLTP
|
[NCBI]
|
1.68886e-06
|
|
|
FGF7
|
[NCBI]
|
1.66789e-06
|
|
|
EPHX1
|
[NCBI]
|
1.62447e-06
|
|
|
TYRP1
|
[NCBI]
|
1.62447e-06
|
|
|
GDF5
|
[NCBI]
|
1.62447e-06
|
|
|
CYP2A6
|
[NCBI]
|
1.62447e-06
|
|
|
INCENP
|
[NCBI]
|
1.62447e-06
|
|
|
IL13
|
[NCBI]
|
1.62447e-06
|
|
|
GHRL
|
[NCBI]
|
1.62447e-06
|
|
|
homocystinuria
|
[NCBI]
|
1.60484e-06
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
1.6045e-06
|
|
|
MCP
|
[NCBI]
|
1.58894e-06
|
|
|
MDC1A
|
[NCBI]
|
1.56576e-06
|
|
|
CNC1
|
[NCBI]
|
1.56576e-06
|
|
|
pulmonary fibrosis, idiopathic
|
[NCBI]
|
1.56576e-06
|
|
|
HHF2
|
[NCBI]
|
1.55956e-06
|
|
|
LNS
|
[NCBI]
|
1.55514e-06
|
|
|
OPRM1
|
[NCBI]
|
1.55172e-06
|
|
|
MDM2
|
[NCBI]
|
1.53386e-06
|
|
|
CTCF
|
[NCBI]
|
1.53386e-06
|
|
|
PAI1
|
[NCBI]
|
1.53386e-06
|
|
|
PHEX
|
[NCBI]
|
1.53386e-06
|
|
|
RPS6KA3
|
[NCBI]
|
1.53386e-06
|
|
|
GATA1
|
[NCBI]
|
1.53386e-06
|
|
|
SLC2A4
|
[NCBI]
|
1.5202e-06
|
|
|
LEP
|
[NCBI]
|
1.5202e-06
|
|
|
ACADS
|
[NCBI]
|
1.44748e-06
|
|
|
CYP3A4
|
[NCBI]
|
1.44748e-06
|
|
|
XPA
|
[NCBI]
|
1.44748e-06
|
|
|
MTCO1
|
[NCBI]
|
1.44748e-06
|
|
|
GK
|
[NCBI]
|
1.44748e-06
|
|
|
RAG1
|
[NCBI]
|
1.44748e-06
|
|
|
SMS
|
[NCBI]
|
1.43592e-06
|
|
|
WRN
|
[NCBI]
|
1.43532e-06
|
|
|
FGF2
|
[NCBI]
|
1.38941e-06
|
|
|
FANCC
|
[NCBI]
|
1.36511e-06
|
|
|
PDE6B
|
[NCBI]
|
1.36511e-06
|
|
|
CHEK2
|
[NCBI]
|
1.36511e-06
|
|
|
FGFR3
|
[NCBI]
|
1.36403e-06
|
|
|
PDYN
|
[NCBI]
|
1.28656e-06
|
|
|
DSG1
|
[NCBI]
|
1.28656e-06
|
|
|
MSD
|
[NCBI]
|
1.26513e-06
|
|
|
EKV
|
[NCBI]
|
1.26513e-06
|
|
|
MADA
|
[NCBI]
|
1.26513e-06
|
|
|
SRY
|
[NCBI]
|
1.21393e-06
|
|
|
GNMT
|
[NCBI]
|
1.21164e-06
|
|
|
STK11
|
[NCBI]
|
1.21164e-06
|
|
|
EDN1
|
[NCBI]
|
1.21164e-06
|
|
|
MYH11
|
[NCBI]
|
1.21164e-06
|
|
|
GC
|
[NCBI]
|
1.20059e-06
|
|
|
LWD
|
[NCBI]
|
1.1959e-06
|
|
|
leber optic atrophy, susceptibility to
|
[NCBI]
|
1.17739e-06
|
|
|
AGER
|
[NCBI]
|
1.17003e-06
|
|
|
SIRT1
|
[NCBI]
|
1.14017e-06
|
|
|
GAA
|
[NCBI]
|
1.14017e-06
|
|
|
H19
|
[NCBI]
|
1.14017e-06
|
|
|
HP
|
[NCBI]
|
1.09395e-06
|
|
|
CPI
|
[NCBI]
|
1.09076e-06
|
|
|
TFR2
|
[NCBI]
|
1.072e-06
|
|
|
MMP3
|
[NCBI]
|
1.072e-06
|
|
|
APRT
|
[NCBI]
|
1.05178e-06
|
|
|
ALGS1
|
[NCBI]
|
1.03061e-06
|
|
|
MTM1
|
[NCBI]
|
1.00912e-06
|
|
|
AMACR
|
[NCBI]
|
1.00698e-06
|
|
|
PG
|
[NCBI]
|
1.00615e-06
|
|
|
CRMO
|
[NCBI]
|
1.00413e-06
|
|
|
myopathy, myofibrillar, desmin-related
|
[NCBI]
|
1.00413e-06
|
|
|
acyl-coa dehydrogenase, medium-chain, deficiency of
|
[NCBI]
|
1.00413e-06
|
|
|
SCDO1
|
[NCBI]
|
1.00413e-06
|
|
|
hyperglycerolemia
|
[NCBI]
|
1.00413e-06
|
|
|
HOKPP
|
[NCBI]
|
1.00413e-06
|
|
|
RHO
|
[NCBI]
|
9.63714e-07
|
|
|
SOX9
|
[NCBI]
|
9.44956e-07
|
|
|
IL2RA
|
[NCBI]
|
8.85813e-07
|
|
|
tyrosinemia, type i
|
[NCBI]
|
8.85813e-07
|
|
|
RUNX1
|
[NCBI]
|
8.85813e-07
|
|
|
EDMD
|
[NCBI]
|
8.75441e-07
|
|
|
PCI
|
[NCBI]
|
8.58092e-07
|
|
|
ATRX
|
[NCBI]
|
8.29421e-07
|
|
|
MTATP6
|
[NCBI]
|
8.29421e-07
|
|
|
VLDLR
|
[NCBI]
|
8.29421e-07
|
|
|
citrullinemia, classic
|
[NCBI]
|
7.7948e-07
|
|
|
ODDD
|
[NCBI]
|
7.7948e-07
|
|
|
OCRL
|
[NCBI]
|
7.7948e-07
|
|
|
hyperekplexia, hereditary
|
[NCBI]
|
7.7948e-07
|
|
|
NEM3
|
[NCBI]
|
7.7948e-07
|
|
|
CPX
|
[NCBI]
|
7.7948e-07
|
|
|
TNFRSF6
|
[NCBI]
|
7.75668e-07
|
|
|
methemoglobinemia due to deficiency of methemoglobin reductase
|
[NCBI]
|
7.75668e-07
|
|
|
TSC1
|
[NCBI]
|
7.75668e-07
|
|
|
PNPLA6
|
[NCBI]
|
7.71791e-07
|
|
|
FGFR1
|
[NCBI]
|
7.71791e-07
|
|
|
TLR5
|
[NCBI]
|
7.24446e-07
|
|
|
AKT1
|
[NCBI]
|
6.75652e-07
|
|
|
WAS
|
[NCBI]
|
6.75652e-07
|
|
|
PLG
|
[NCBI]
|
6.73026e-07
|
|
|
factor vii deficiency
|
[NCBI]
|
6.29192e-07
|
|
|
TLR2
|
[NCBI]
|
5.9815e-07
|
|
|
HAE
|
[NCBI]
|
5.97418e-07
|
|
|
adrenoleukodystrophy, autosomal neonatal form
|
[NCBI]
|
5.97418e-07
|
|
|
ESD
|
[NCBI]
|
5.9578e-07
|
|
|
BPES
|
[NCBI]
|
5.924e-07
|
|
|
NF1
|
[NCBI]
|
5.90035e-07
|
|
|
hepatocellular carcinoma
|
[NCBI]
|
5.88253e-07
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
5.88253e-07
|
|
|
ALMS
|
[NCBI]
|
5.88253e-07
|
|
|
DSG3
|
[NCBI]
|
5.84977e-07
|
|
|
isoniazid inactivation
|
[NCBI]
|
5.84977e-07
|
|
|
HS
|
[NCBI]
|
5.84977e-07
|
|
|
PVR
|
[NCBI]
|
5.84977e-07
|
|
|
CCND1
|
[NCBI]
|
5.72035e-07
|
|
|
GJB1
|
[NCBI]
|
5.51066e-07
|
|
|
SPINK1
|
[NCBI]
|
5.48657e-07
|
|
|
B2M
|
[NCBI]
|
5.02944e-07
|
|
|
RLBP1
|
[NCBI]
|
5.02944e-07
|
|
|
KCNH2
|
[NCBI]
|
4.92694e-07
|
|
|
UCP2
|
[NCBI]
|
4.80777e-07
|
|
|
CDSP
|
[NCBI]
|
4.75606e-07
|
|
|
pyruvate kinase deficiency of red cells
|
[NCBI]
|
4.75606e-07
|
|
|
PROCR
|
[NCBI]
|
4.64971e-07
|
|
|
SLC18A2
|
[NCBI]
|
4.2893e-07
|
|
|
KIT
|
[NCBI]
|
4.2893e-07
|
|
|
OTC
|
[NCBI]
|
4.2893e-07
|
|
|
INSL3
|
[NCBI]
|
4.2893e-07
|
|
|
HBFQTL1
|
[NCBI]
|
4.27881e-07
|
|
|
TLR9
|
[NCBI]
|
4.16412e-07
|
|
|
A2M
|
[NCBI]
|
3.94754e-07
|
|
|
LBR
|
[NCBI]
|
3.94754e-07
|
|
|
PARG
|
[NCBI]
|
3.94754e-07
|
|
|
MODY
|
[NCBI]
|
3.80647e-07
|
|
|
DMD
|
[NCBI]
|
3.76923e-07
|
|
|
F2
|
[NCBI]
|
3.62377e-07
|
|
|
EV
|
[NCBI]
|
3.51843e-07
|
|
|
SLC2A2
|
[NCBI]
|
3.3174e-07
|
|
|
PCD
|
[NCBI]
|
3.15101e-07
|
|
|
PPSH
|
[NCBI]
|
2.96078e-07
|
|
|
HSAS
|
[NCBI]
|
2.96078e-07
|
|
|
TCOF
|
[NCBI]
|
2.95189e-07
|
|
|
PGK1
|
[NCBI]
|
2.75454e-07
|
|
|
TRPS2
|
[NCBI]
|
2.69294e-07
|
|
|
BTHS
|
[NCBI]
|
2.69294e-07
|
|
|
growth hormone insensitivity syndrome
|
[NCBI]
|
2.69294e-07
|
|
|
PC
|
[NCBI]
|
2.63343e-07
|
|
|
AQP4
|
[NCBI]
|
2.49698e-07
|
|
|
NOS3
|
[NCBI]
|
2.49698e-07
|
|
|
GSC
|
[NCBI]
|
2.49698e-07
|
|
|
CALCRL
|
[NCBI]
|
2.46243e-07
|
|
|
PIGR
|
[NCBI]
|
2.13488e-07
|
|
|
GRB2
|
[NCBI]
|
2.02709e-07
|
|
|
RP1
|
[NCBI]
|
1.90801e-07
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
1.90801e-07
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
1.90801e-07
|
|
|
testicular tumors
|
[NCBI]
|
1.90801e-07
|
|
|
apert syndrome
|
[NCBI]
|
1.90801e-07
|
|
|
alzheimer disease 3
|
[NCBI]
|
1.90801e-07
|
|
|
HYPP
|
[NCBI]
|
1.86098e-07
|
|
|
breast cancer
|
[NCBI]
|
1.7667e-07
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
1.7667e-07
|
|
|
TBP
|
[NCBI]
|
1.62393e-07
|
|
|
glaucoma-related pigment dispersion syndrome
|
[NCBI]
|
1.62189e-07
|
|
|
PAND1
|
[NCBI]
|
1.62189e-07
|
|
|
JAK3
|
[NCBI]
|
1.61444e-07
|
|
|
FOXP3
|
[NCBI]
|
1.61444e-07
|
|
|
BCL2
|
[NCBI]
|
1.61444e-07
|
|
|
VIM
|
[NCBI]
|
1.54011e-07
|
|
|
SOCS3
|
[NCBI]
|
1.42851e-07
|
|
|
NMU
|
[NCBI]
|
1.42851e-07
|
|
|
SDS
|
[NCBI]
|
1.26635e-07
|
|
|
GCCR
|
[NCBI]
|
1.25564e-07
|
|
|
IL4
|
[NCBI]
|
1.14987e-07
|
|
|
STL1
|
[NCBI]
|
1.10222e-07
|
|
|
MCOPS7
|
[NCBI]
|
1.10222e-07
|
|
|
homocysteinemia
|
[NCBI]
|
1.10222e-07
|
|
|
HHC1
|
[NCBI]
|
1.10222e-07
|
|
|
NR5A1
|
[NCBI]
|
1.09546e-07
|
|
|
CTNNB1
|
[NCBI]
|
1.09546e-07
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
1.09546e-07
|
|
|
DGS
|
[NCBI]
|
9.87986e-08
|
|
|
CCL2
|
[NCBI]
|
9.47596e-08
|
|
|
DSPP
|
[NCBI]
|
9.47596e-08
|
|
|
ANG
|
[NCBI]
|
8.1171e-08
|
|
|
IHH
|
[NCBI]
|
7.34776e-08
|
|
|
MECP2
|
[NCBI]
|
6.79832e-08
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
6.42308e-08
|
|
|
FIH
|
[NCBI]
|
6.32864e-08
|
|
|
WFS1
|
[NCBI]
|
6.32864e-08
|
|
|
PENK
|
[NCBI]
|
5.74545e-08
|
|
|
ABCC2
|
[NCBI]
|
5.25558e-08
|
|
|
HBA1
|
[NCBI]
|
4.9006e-08
|
|
|
NR0B2
|
[NCBI]
|
4.72642e-08
|
|
|
THRB
|
[NCBI]
|
4.72642e-08
|
|
|
FSHR
|
[NCBI]
|
4.72642e-08
|
|
|
LOX
|
[NCBI]
|
4.72642e-08
|
|
|
TPO
|
[NCBI]
|
4.41834e-08
|
|
|
PTEN
|
[NCBI]
|
3.97337e-08
|
|
|
PAX6
|
[NCBI]
|
3.00723e-08
|
|
|
HPS
|
[NCBI]
|
2.5645e-08
|
|
|
XLP1
|
[NCBI]
|
2.53238e-08
|
|
|
mitochondrial complex i deficiency
|
[NCBI]
|
2.53238e-08
|
|
|
campomelic dysplasia
|
[NCBI]
|
2.53238e-08
|
|
|
SJS1
|
[NCBI]
|
2.53238e-08
|
|
|
WBS
|
[NCBI]
|
2.46958e-08
|
|
|
ichthyosis, x-linked
|
[NCBI]
|
2.35607e-08
|
|
|
XIST
|
[NCBI]
|
2.30155e-08
|
|
|
APP
|
[NCBI]
|
1.81495e-08
|
|
|
BTK
|
[NCBI]
|
1.80147e-08
|
|
|
TERT
|
[NCBI]
|
1.53878e-08
|
|
|
BMP2
|
[NCBI]
|
1.18496e-08
|
|
|
hypertension, essential
|
[NCBI]
|
8.42931e-09
|
|
|
ALS1
|
[NCBI]
|
8.42931e-09
|
|
|
SLC11A2
|
[NCBI]
|
7.69128e-09
|
|
|
SERPINA6
|
[NCBI]
|
5.38901e-09
|
|
|
EVA
|
[NCBI]
|
4.21268e-09
|
|
|
CMD1A
|
[NCBI]
|
4.21268e-09
|
|
|
apc gene
|
[NCBI]
|
4.17924e-09
|
|
|
PLN
|
[NCBI]
|
3.10105e-09
|
|
|
SLC6A4
|
[NCBI]
|
2.55671e-09
|
|
|
hemophilia a
|
[NCBI]
|
2.54746e-09
|
|
|
FGFR2
|
[NCBI]
|
2.53114e-09
|
|
|
ARNT
|
[NCBI]
|
2.10774e-09
|
|
|
CMT1A
|
[NCBI]
|
1.94963e-09
|
|
|
EIG
|
[NCBI]
|
1.16959e-09
|
|
|
CVS
|
[NCBI]
|
9.74364e-10
|
|
|
hypogonadotropic hypogonadism
|
[NCBI]
|
5.84253e-10
|
|